clinical_trial_age_range: 18 years to 45 years

name: A Study to Assess the Safety of Adacel® Vaccine


clinical_trial_tested_intervention: unsure

clinical_trial_overall_status: COMPLETED

clinical_trial_enrollment_type: ACTUAL

clinical_trial_age_range: 18 years or older

clinical_trial_primary_purpose: TREATMENT

name: Lurbinectedin (PM01183) Combined With Pembrolizumab in Small Cell Lung Cancer.


clinical_trial_age_range: 5 years to 18 years

clinical_trial_intervention_model: PARALLEL

name: Ketamine Versus Etomidate for Procedural Sedation for Pediatric Orthopedic Reductions

original_conditions: Conscious Sedation Failure During Procedure


clinical_trial_tested_intervention: yes

clinical_trial_age_range: 40 years or older

name: Safety of Single Doses of SAR113945 and Efficacy and Safety of a New Formulation Given Into the Knee in Osteoarthritis Patients / Part I


name: Topical Imiquimod Cream in Combination With Cryotherapy for the Treatment of Actinic Keratoses


clinical_trial_overall_status: TERMINATED

name: Prevention of Metabolic Syndrome and Increased Weight Using Metformin Concurrent to Androgen Deprivation Therapy and Radiotherapy for Locally Advanced Adenocarcinoma of the Prostate


name: An Open-label Study of Encorafenib + Binimetinib in Patients With BRAFV600-mutant Non-small Cell Lung Cancer


clinical_trial_overall_status: UNKNOWN

clinical_trial_age_range: 40 years to 90 years

name: Kinetics of the Finasteride Prostate Induced Apoptosis


clinical_trial_age_range: 18 years to 80 years

name: A Study to Assess the Analgesic Efficacy and Safety of ASP0819 in Patients With Fibromyalgia


clinical_trial_age_range: up to 21 years

name: Donor Bone Marrow Transplant With or Without G-CSF in Treating Young Patients With Hematologic Cancer or Other Diseases

original_conditions: Chronic Phase Chronic Myelogenous Leukemia

original_conditions: Recurrent Childhood Acute Lymphoblastic Leukemia

original_conditions: Childhood Acute Myeloid Leukemia in Remission

original_conditions: Childhood Acute Lymphoblastic Leukemia in Remission

original_conditions: Previously Treated Myelodysplastic Syndromes


name: Safety and Tumoricidal Effect of Low Dose Foscan PDT in Patients With Inoperable Bile Duct Cancers


name: Dose-Escalation and Dose-Expansion Study of IO-202 and IO-202+Pembrolizumab in Solid Tumors


clinical_trial_enrollment_type: ESTIMATED

clinical_trial_age_range: 45 years to 80 years

name: Thalidomide Plus Peginterferon and Ribavirin in Patients With Interferon Resistance


clinical_trial_age_range: 18 years to 65 years

clinical_trial_primary_purpose: PREVENTION

name: Free Fatty Acids-Induced Hypertension in Obese Subjects (Aim #2)


name: Hydroxyurea and Erythropoietin to Treat Sickle Cell Anemia


clinical_trial_age_range: 18 years to 70 years

name: Effect of Amlodipine Versus Amlodipine Combined With Atorvastatin on the Coronary Vasospastic Angina


clinical_trial_age_range: 16 years to 60 years

clinical_trial_intervention_model: FACTORIAL

name: AML2003 - Standard-Therapy vs Intensified Therapy for Adult Acute Myeloid Leukemia Patients <= 60 Years


clinical_trial_age_range: 18 years to 50 years

name: A Study of [14C]GB491 in Male Healthy Subjects


name: Clinical Trial Evaluating the Activity of Zanidatamab for the Treatment of Patients With Solid Tumors With an Alteration of the HER2 Gene.


clinical_trial_age_range: 18 years to 79 years

name: Glycemic Holter Study (Continuous Glucose Monitoring) -


clinical_trial_age_range: 18 years to 75 years

name: Methadone in THA for Post-op Pain and Opioid Reduction


clinical_trial_overall_status: RECRUITING

clinical_trial_primary_purpose: DIAGNOSTIC

name: 18F-Fluoroazomycin Arabinoside (18F-FAZA) in Lung Cancer


clinical_trial_age_range: 18 years to 60 years

name: The Effect of Natalizumab (Tysabri) on Sexual Dysfunction in Multiple Sclerosis


Neuroimaging of Dystonia

clinical_trial_age_range: 7 years to 70 years

clinical_trial_time_perspective: PROSPECTIVE


clinical_trial_age_range: 19 years to 75 years

clinical_trial_intervention_model: CROSSOVER

name: Assessment of Chronic Guillain-Barre Syndrome Improvement With Use of 4-aminopyridine


clinical_trial_overall_status: WITHDRAWN

name: Fatty Acids in Airway Smooth Muscle of Asthmatics


clinical_trial_age_range: 4 years to 55 years

name: Clinical Study Using Biologics to Improve Multi OIT Outcomes (COMBINE)

original_conditions:
Peanut Allergy
Peanut Hypersensitivity

original_conditions:
Food Allergy
Hypersensitivity, Food


clinical_trial_age_range: 18 years or older

name: Photodynamic Therapy Using Temoporfin Before Surgery in Treating Patients With Recurrent Oral Cavity or Oropharyngeal Cancer

original_conditions: Stage I Squamous Cell Carcinoma of the Lip and Oral Cavity

original_conditions: Stage I Verrucous Carcinoma of the Oral Cavity

original_conditions: Stage II Squamous Cell Carcinoma of the Lip and Oral Cavity

original_conditions: Stage II Verrucous Carcinoma of the Oral Cavity

original_conditions: Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity

original_conditions: Recurrent Verrucous Carcinoma of the Oral Cavity

original_conditions: Stage I Squamous Cell Carcinoma of the Oropharynx

original_conditions: Stage II Squamous Cell Carcinoma of the Oropharynx

original_conditions: Recurrent Squamous Cell Carcinoma of the Oropharynx


name: A Study to Assess Safety and Effectiveness of Elafibranor in Adult Participants With Primary Sclerosing Cholangitis.


name: Nitrite Effects on Cardiac Muscle in CABG


name: 2015-09: a Phase II Randomized, Open-label Study of Anti-signaling Lymphocytic Activation Molecule Monoclonal Antibody During Maintenance Therapy


clinical_trial_primary_purpose: OTHER

name: A Phase I/II Study With BM7PE Immunotoxin in Colorectal Cancer Patients


name: PhIb BKM120 or BEZ235+Endocrine Treatment in Post-Menopausal Patients With Hormone Receptor + Metastatic Breast Cancer


name: Preference for Clarinex Tablets vs. Allegra Tablets in Patients With Seasonal Allergies (Study P03177)


clinical_trial_age_range: 21 years to 55 years

name: Behavioral Effects of Drugs: Inpatient (36) (Alcohol, Duloxetine, and Methylphenidate)


name: Safety of Cetuximab and Oxaliplatin/5-FU/FA/Irinotecan in First-Line Treatment of Metastatic Colorectal Cancer


name: Vitamin K to Attenuate Coronary Artery Calcification in Hemodialysis Patients


clinical_trial_age_range: 21 years to 65 years

name: Effects of a Dietary Supplement Containing Salacia Extract, Citrus Bioflavonoids, and Trivalent Chromium on Markers of Glucose Control


name: Study of AntiCTLA4 in Patients With Unresectable or Metastatic Uveal Melanoma


name: Aviptadil for Severely Ill Inpatients With COVID-19 (An ACTIV-3b/TESICO Treatment Trial)


clinical_trial_age_range: any age

name: Caffeine Citrate Use and Electronic Activity of the Diaphragm (EDI) Changes


clinical_trial_age_range: 18 years to 45 years

name: Effect of Vitis Vinifera Extract on Oxidative Stress, Inflamatory Biomarkers and Hormones in High Trained Subjects


clinical_trial_age_range: 20 years to 75 years

name: A Study to Compare P1101 Plus TAF With or Without UDCA in Patients With HBV and HDV Co-Infection


clinical_trial_age_range: 50 years or older

name: A Study to Evaluate the Long-Term Safety and Tolerability of Faricimab in Participants With Neovascular Age-Related Macular Degeneration

original_conditions: Neovascular Age-related Macular Degeneration


clinical_trial_age_range: 18 years to 80 years

name: Phase II Study of GIVINOSTAT (ITF2357) in Combination With Hydroxyurea in Polycythemia Vera


name: Combination Chemotherapy, Radiation Therapy, and Bevacizumab in Treating Patients With Newly Diagnosed Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery

original_conditions: Stage IIIA Lung Non-Small Cell Cancer AJCC v7

original_conditions: Stage IIIB Lung Non-Small Cell Cancer AJCC v7


name: Multiple Daily Doses Of Aspirin To Overcome Aspirin Hyporesponsiveness Post Cardiac Bypass Surgery

original_conditions: Postoperative; Dysfunction Following Cardiac Surgery


clinical_trial_age_range: 16 years to 65 years

name: Chemotherapy Before Autologous Stem Cell Transplantation +/- Rituximab in Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma


clinical_trial_age_range: 20 years or older

name: MSB0011359C (M7824) in Participants With Metastatic or Locally Advanced Solid Tumors


clinical_trial_age_range: 15 years to 60 years

name: Effect of Acitretin Versus Narrowband Ultraviolet B on Neopterin Level in Psoriatic Patients .


clinical_trial_intervention_model: SEQUENTIAL

name: Pitavastatin in Combination With Venetoclax for Chronic Lymphocytic Leukemia or Acute Myeloid Leukemia

original_conditions:
CLL
Chronic Lymphocytic Leukemia


name: A Phase I Study of Zalypsis (PM00104) in Subjects With Advanced Malignant Solid Tumors or Lymphoma


name: A Study of Intratumoral Administration of Oncolytic Virus Injection (RT-01) in Patients With Advanced Solid Tumors


name: A Pilot Study of XOMA 052 in Familial Cold Autoinflammatory Syndrome / Muckle-Wells Syndrome and Behcet's Disease


clinical_trial_age_range: 40 years to 85 years

name: A Study of CM310 in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease


clinical_trial_age_range: 18 years to 75 years

name: Psoriasis Inflammation and Systemic Co Morbidities


name: Safety and Efficacy Study of KAI-1678 to Treat Pain in Subjects With Spinal Cord Injury


name: Safety Study of Oral MGCD265 Administered Without Interruption to Subjects With Advanced Malignancies


clinical_trial_age_range: 20 years to 38 years

name: Prospective Clinical Study of Nintedanib to Inhibit Endometrial Fibrosis to Prevent Recurrence of Uterine Adhesions

original_interventions:
Nintedanib 100 MG [Ofev]
Nintedanib 150 MG [Ofev]


clinical_trial_age_range: 18 years to 85 years

name: Safety and Efficacy of Thymosin Beta 4 Ophthalmic Solution in Patients With Dry Eye

original_conditions:
Dry Eye
Dry Eye Syndrome


name: Efficacy and Safety Study of a New Therapeutic Strategy in the Treatment of Extended-Disease Small-Cell Lung Cancer


clinical_trial_age_range: 18 years to 55 years

name: Amiloride Hydrochloride as an Effective Treatment for ADHD


clinical_trial_age_range: 18 years to 65 years

name: INflammation-based Stratification for Immune-Targeted Augmentation in Major Depressive Disorder


clinical_trial_age_range: 18 years or older

name: Efficacy of Ginseng for Patients on Regorafenib


name: Multicentric Randomised Trial for Resectable Gastric Cancer


name: Study of Pembrolizumab (MK-3475) Versus Platinum-Based Chemotherapy for Participants With Programmed Cell Death-Ligand 1 (PD-L1)-Positive Advanced or Metastatic Non-Small Cell Lung Cancer (MK-3475-042/KEYNOTE-042)-China Extension Study


name: Heamodynamic Effects of Paracetamol in Septic Shock Patients


name: Alvimopan For The Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain


clinical_trial_age_range: 65 years or older

name: Cognitive Protection - Dexmedetomidine and Cognitive Reserve

original_interventions: Dexmedetomidine Precedex


name: Phase 1 Every-3-Week Dosing of SCH 727965 in Patients With Advanced Cancer (Study P04630)


name: Pilot Trial of Acamprosate for the Treatment of Cocaine Dependence


clinical_trial_age_range: 3 months to 17 years

name: Aztreonam Lysine for Pseudomonas Infection Eradication Study


name: Assessment of Quizartinib Pharmacokinetic in Subjects With Severe Hepatic Impairment


name: Testing Palbociclib (PD-0332991) as a Potential Targeted Treatment in Cancers With CCND1, 2, 3 Amplification (MATCH-Subprotocol Z1B)

original_conditions: Hematopoietic and Lymphoid Cell Neoplasm


clinical_trial_age_range: 18 years to 99 years

name: A Phase 2, Open-label, Randomized, Multicenter Study of Tarlatamab Dosing Regimens in Subjects With SCLC


clinical_trial_age_range: 18 years to 130 years

name: Phase 3 28-Week Study With 24-Week and 52-week Extension Phases to Evaluate Efficacy and Safety of Exenatide Once Weekly and Dapagliflozin Versus Exenatide and Dapagliflozin Matching Placebo


Effects of Galantamine on Cognition

clinical_trial_age_range: 18 years to 64 years


name: A Randomized Pilot Study of Evolocumab Plus Nivolumab/Ipilimumab in Treatment-Naïve Patients With Metastatic NSCLC


clinical_trial_age_range: 18 years to 70 years

name: Empirical Rescue Therapies of Helicobacter Pylori Infection


name: Efficacy and Safety of Lanreotide Autogel (ATG) in Combination With Temozolomide in Subjects With Thoracic Neuroendocrine Tumors.


name: A Study of Capecitabine (Xeloda) as First-Line Chemotherapy in Participants With Metastatic Nasopharyngeal Cancer


name: Individualized Treatment Strategy for Patients With Metastatic Non-clear Cell Renal Cell Carcinoma


clinical_trial_time_perspective: RETROSPECTIVE

name: Non-interventional Study for Real-world Data of Afatinib Treatment in First-line Setting and of Subsequent Therapies for Patients With Advanced Epidermal Growth Factor Receptor (EGFR) Mutation-positive Lung Adenocarcinoma

original_conditions: Non-squamous, Non-Small Cell Lung Cancer


name: Study To Assess Renewal Of Treatment In Patients Recently Diagnosed With Prostate Cancer


name: Exploring Whether Disease-free Intervals Can Guide Endocrine Combined Targeted Therapy for ER+/HER2+ Advanced Breast Cancer (T-sunflower)


clinical_trial_age_range: 20 years to 60 years

name: Comparison Between Sevoflurane and Propofol for Maintenance of Sedation During ERCP


name: Study of GSK3965193 in Healthy Participants and Participants Living With Chronic Hepatitis B Infection


name: MLN8237 in Patients With Relapsed or Refractory Aggressive B-Cell Lymphoma Treated With Rituximab +/- Vincristine


name: Recombinant EphB4-HSA Fusion Protein and Pembrolizumab, MK-3475


name: Combination Drug-Therapy for Patients With Untreated Obstructive Sleep Apnea

original_conditions:
OSA
Obstructive Sleep Apnea


clinical_trial_age_range: 20 years to 53 years

name: To Demonstrate the Relative Bioavailability of Cetirizine Hydrochloride/Pseudoephedrine Hydrochloride 5 mg/120 mg Extended Release (ER) Tablets Under Fed Conditions


name: PKC412 in Participants With Acute Myeloid Leukemia or With Myelodysplastic Syndrome (CPKC412A2104 Core); and PKC412 in Participants With Acute Myeloid Leukemia or With Myelodysplastic Syndrome With Either Wild Type or Mutated FMS-like Tyrosine Kinase 3 (FLT3) (CPKC412A2104E1 and CPKC412A2104E2)


clinical_trial_time_perspective: OTHER

name: Spanish Real-World Evidence Cabozantinib


clinical_trial_age_range: 18 years to 80 years

name: Effect of Moderate Renal Impairment and Race/Ethnicity on Treosulfan Pharmacokinetics


name: Open-Label Study of Oral CEP-701 (Lestaurtinib) in Patients With Polycythemia Vera or Essential Thrombocytosis


clinical_trial_age_range: 12 years or older

name: A Study to Evaluate the Efficacy and Safety of Narlumosbart (JMT103) in Patients With Giant Cell Tumor of Bone


name: Vinorelbine/Carboplatin Versus Gemcitabine/Carboplatin in Metastatic Breast Cancer


name: Efficacy and Safety Study of Dexmedetomidine as an Additive to Local Anesthetics in Shoulder Surgery


name: Study to Assess Safety and Tolerability of AG013 in Oral Mucositis in Subjects Receiving Induction Chemotherapy for the Treatment of Cancers of the Head and Neck


name: Effects of Flumazenil on Recovery After Total Intravenous Anesthesia With Remimazolam


clinical_trial_age_range: 40 years or older

name: Fesoterodine add-on Male Overactive Bladder Study


clinical_trial_age_range: 40 years to 84 years

name: Randomized Trial of Aspirin and Cataracts in U.S. Physicians


clinical_trial_age_range: 16 years or older

name: Administration of High-Dose Intravenous Proton Pump Inhibitor for Upper Gastrointestinal Bleeding Prior to Endoscopy


clinical_trial_age_range: 14 years to 30 years

name: Ketamine Treatment of Youth Suicide Attempters


clinical_trial_age_range: 18 years to 60 years

name: Efficacy of Prednisolone Versus Cerebrolysin in the Treatment of Bell's Palsy


name: Efficacy and Safety Study of Vandetanib (ZD 6474) in Combination With Bicalutamide Versus Bicalutamide Alone in Patients With Chemotherapy Naive Hormone Refractory Prostate Cancer.


name: Effects of Riociguat on RIght VEntricular Size and Function in PAH and CTEPH

original_conditions: Chronic Thromboembolic Pulmonary Hypertension


clinical_trial_age_range: 18 years to 100 years

name: A Study of Oraxol in Subjects With Cutaneous Angiosarcoma


clinical_trial_age_range: 18 years or older

name: ComparisoN of ticAgrelor vs. Clopidogrel in endoTHeliAl Function of COPD patieNts


clinical_trial_age_range: 2 years to 21 years

name: Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Promyelocytic Leukemia

original_conditions: Childhood Acute Promyelocytic Leukemia With PML-RARA


name: Investigation of Naltrexone for Pathological Gambling


name: A Study of Shorter Course Hormone Therapy and Radiation for High-risk Prostate Cancer


name: Non-interventional, Post Marketing Surveillance Study of Xultophy™ (Insulin Degludec/Liraglutide) to Evaluate Long Term Safety and Efficacy in Patients With Type 2 Diabetes Mellitus in Routine Clinical Practice in India

original_conditions:
Diabetes
Diabetes Mellitus, Type 2


clinical_trial_age_range: 19 years to 65 years

name: A Randomized Phase II Trial to Compare the Safety and Neutralizing Activity of CL184 in Combination With Rabies Vaccine vs. HRIG or Placebo in Combination With Rabies Vaccine in Healthy Adult Subjects


name: Study Evaluating Pembrolizumab +/- Olaparib in TLS Positive Selected Resectable STS Followed by Adjuvant Pembrolizumab


clinical_trial_age_range: 42 days to 64 days

name: Immunogenicity, Safety and Tolerability of a Fully Liquid Pentavalent (DTwP-Hib-Hep B) Vaccine in Infants 6-8 Weeks of Age


clinical_trial_age_range: 2 years to 35 years

name: Testing the Combination of Two Immunotherapy Drugs (Magrolimab and Dinutuximab) in Patients With Relapsed or Refractory Neuroblastoma or Relapsed Osteosarcoma


clinical_trial_age_range: 21 years or older

name: Functional Imaging of Tremor Circuits and Mechanisms of Treatment Response


name: Bioenergetic Effect of Pioglitazone in CLD-PH


name: Phase 2, Endocrine Therapy + OSI-906 With or Without Erlotinib for Hormone-sensitive Metastatic Breast Cancer


name: The Efficacy of Different Anti-viral Drugs in COVID 19 Infected Patients

original_conditions: Acute Respiratory Distress Syndrome ARDS


name: A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma


clinical_trial_age_range: 3 years to 6 years

name: Efficacy and Safety Study of Ingavirin® to Treat Influenza and Other Acute Respiratory Viral Infections in Patients 3-6 y.o.


name: Safety and Pharmacokinetics of Recombinant Factor XIII in Patients With Congenital Factor Xlll Deficiency


clinical_trial_age_range: 30 years to 75 years

name: Effect of Ezetimibe Plus Simvastatin Versus Simvastatin Alone on Atherosclerosis in the Carotid Artery (ENHANCE)(P02578)


name: A Study Evaluating the Safety and Efficacy of AUR107 in Patients With Relapsed Advanced Malignancies (SHAKTI-1)


name: First-in-human Phase I Study to Evaluate Safety, Tolerability and Antineoplastic Activity of OATD-02 in Patients with Selected Advanced And/or Metastatic Solid Tumours


name: Efficacy and Safety of the Combination of Trastuzumab Plus TUCAtinib Plus viNorelbine in Patients With HER2-positive Non-resectable Locally Advanced or Metastatic Breast Cancer

original_conditions: Locally Advanced HER2 Positive Breast Carcinoma


name: Study To Investigate the Efficacy and Safety of Sitravatinib in Combination With Tislelizumab in Participants With Esophageal Squamous Cell Carcinoma


clinical_trial_age_range: 13 years or older

name: A Study of Itraconazole in the Prevention of Histoplasmosis, a Fungal Infection, in HIV-Infected Patients


clinical_trial_age_range: 19 years to 54 years

name: Effects of Azithromycin as an Adjunct to Scaling and Root Planning in the Treatment of Periodontitis


name: Safety of PZ-128 in Subjects Undergoing Non-Emergent Percutaneous Coronary Intervention

original_conditions:
Coronary Artery Disease
Coronary Disease

original_conditions:
Coronary Artery Disease
Myocardial Ischemia


name: LDE225 in Patients With Advanced or Metastatic Hepatocellular Carcinoma and Child-Pugh A/B7 Cirrhosis


name: Study of Gemcitabine, Carboplatin and VELIPARIB (ABT-888) in Refractory Testicular Germ Cell Cancer


clinical_trial_age_range: 20 years or older

name: Effects of Combined Therapy With Statin Plus Fenofibrate on Coronary Atherosclerotic Plaque Compared With Statin Alone


name: Combination of Novel Therapies for CKD Comorbid Depression


clinical_trial_age_range: any age

name: PS-341 (VELCADE™) Versus High-Dose Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma


clinical_trial_age_range: 18 years to 75 years

name: Evaluate the Safety, Tolerability, Pharmacodynamics and Efficacy of CNP-106 in Subjects With Myasthenia Gravis


name: Efficacy and Safety of SHR0302 in Patients With Relapsed/Refractory Peripheral T/NK Cell Lymphoma


name: Sphenopalatine Ganglion Block and Cold Induced Headaches


name: Post-marketing Surveillance on Long Term Use of Ofev Capsules in Systemic Scleroderma Associated Interstitial Lung Disease (SSc-ILD) in Japan


clinical_trial_age_range: 18 years to 45 years

name: Dextroamphetamine as Adjunct in Cocaine/Opiate Dependent Patients - 3


name: Sacituzumab Govitecan and Intrathecal Chemotherapy for Treating Leptomeningeal Metastases From Her2-negative Breast Cancer


name: Granulocyte Macrophage-Colony Stimulating Factor and Ipilimumab as Therapy in Melanoma


ARIpiprazole in Anorexia NErvosa

clinical_trial_age_range: 12 years to 18 years


clinical_trial_age_range: 18 years to 65 years

name: Evaluating the Protective Effect of Pentoxifylline on Contrast Induced Nephropathy


name: Study of Oral Bisphosphonate for Osteopenic Women Treated With Adjuvant Aromatase Inhibitors


clinical_trial_age_range: 2 years to 80 years

name: Genetic Factors of the Desmopressin Response in Carriers of Hemophilia A


clinical_trial_age_range: 18 years or older

name: Study of BMN-673 With Carboplatin and Paclitaxel in Patients With Advanced BRCA-mutated Solid Tumor or Triple Negative Metastatic Breast Cancer


name: Pazopanib in Treating Patients With Malignant Pleural Mesothelioma


name: Study of Indomethacin Capsules to Treat Pain Following Bunionectomy


clinical_trial_age_range: 25 years to 39 years

name: Dose Modification Requirement for Trelagliptin in Egyptian Population


clinical_trial_age_range: 4 years to 17 years

name: Polyethylene Glycol and Intestinal Inflammation in Cystic Fibrosis

original_interventions:
Macrogol 4000
polyethylene glycol


name: Neoadjuvant Carboplatin and Docetaxel in Triple Negative Breast Cancer


name: Novaferon for COVID-19 Treatment Trial (NCTT-005)


clinical_trial_age_range: 18 years to 80 years

name: Interval Cytoreductive Surgery With or Without HIPEC for Ovarian Cancer


name: Phase II Docetaxel / Carboplatin / XRT + Surgical Resection in Stage III NSCLC


clinical_trial_age_range: 18 years to 50 years

name: Low-dose Iron Supplementation in Non-anaemic Iron-deficient Women


clinical_trial_age_range: 60 years or older

name: Perioperative Methadone Compared to Placebo in Elderly Hip Fracture Patients


name: A Randomized, Placebo-controlled, Double-blind Study of KLH-2109 in Patients With Endometriosis (2)


name: Efficacy and Safety of Brodalumab Compared With Guselkumab in the Treatment of Plaque Psoriasis After Inadequate Response to Ustekinumab


name: Trilaciclib, a CDK 4/6 Inhibitor, in Patients With Advanced/Metastatic Bladder Cancer Receiving Chemotherapy Then Avelumab


name: Assessing the Efficacy of Clomiphene Citrate in Patients With Azoospermia and Hypoandrogenism


clinical_trial_age_range: 6 weeks to 20 weeks

name: Introduction of an Oral Live Human Rotavirus (Rotarix) Vaccine in Matlab


clinical_trial_age_range: 2 years to 6 years

name: Comparison of the Salivary Levels of Streptococcus Mutans in Pediatric Patients With Early Childhood Caries After the Application of Silver Diamine Fluoride or 5% Sodium Fluoride Varnish


name: A Phase 1 Dose Escalating Trial of Bortezomib in Combination With Lenalidomide in Patients With Myelodysplasia


clinical_trial_age_range: 16 years to 70 years

name: A Study of SHR-1210 Plus Apatinib in Patients With Soft Tissue Sarcoma


clinical_trial_age_range: 15 years to 90 years

name: Cold Stored Platelet in Hemorrhagic Shock


name: Antibiotic Prophylaxis in Patients Undergoing Elective Total Knee Arthroplasty- Multi-center Trial


name: Nivolumab Plus Rituximab in First-line Follicular Lymphoma gr 1-3A


clinical_trial_age_range: 18 years to 85 years

name: Lesinurad Monotherapy in Gout Subjects Intolerant to Xanthine Oxidase Inhibitors


name: Phase II Study of PET Guided Neoadjuvant Chemotherapy (NAC) and Oncotype Guided Hormonal Therapy of Breast Cancer

original_conditions: Infiltrating Duct and Lobular Carcinoma In Situ


name: 4SC-202 in Combination With Pembrolizumab in Patients Primary Refractory/Non-responding to Prior Anti-PD-1 Therapy


name: Regular Use Tiotropium and Tolerance to Bronchoprotection in Mild Asthma


name: Evaluating the Safety, Tolerability, and Pharmacokinetics of Bedaquiline and Delamanid, Alone and in Combination, For Drug-Resistant Pulmonary Tuberculosis


clinical_trial_age_range: 18 years to 70 years

name: Neoadjuvant SLOT Versus SOX in Patients With Locally Advanced, Resectable Gastric/Esophagogastric Junction (EGJ) Cancer


clinical_trial_age_range: 18 years to 75 years

name: Post Marketing Surveillance On The Safety And Tolerability Of Sunitinib Malate (Sutent) For Filipino Patients


name: Safety Study to Evaluate the Contact Sensitizing Potential of Topically Applied ZuraPrep™ and ZuraPrep™ Without IPA


clinical_trial_age_range: 20 years to 70 years

name: A Phase II Study of Locally Advanced Pancreatic Cancer


clinical_trial_age_range: 40 years to 75 years

name: A Study to Assess the Effect of CK-2127107 on Physical Function in Subjects With Chronic Obstructive Pulmonary Disease

original_conditions: Chronic Obstructive Pulmonary Disease (COPD)


clinical_trial_age_range: 18 years to 65 years

name: Weekly Paclitaxel and Cyclophosphamide in Metronomic Administration : Dose Escalation Study of Weekly Paclitaxel


name: Stem Cell Transplant With or Without Tbo-filgrastim in Treating Patients With Multiple Myeloma or Non-Hodgkin Lymphoma


name: Safety, Pharmacokinetics, and Food Effect of PS1 in Subjects


name: Coronary Artery Ectasia, Efficacy of Various Anti Thrombotic Regimens.


name: Efficacy and Safety Study of Chromium Picolinate + Biotin on Glucose and Cholesterol Control in T2DM


clinical_trial_age_range: 21 years to 70 years

name: Tissue Sodium Quantification in Patients With Primary Aldosteronism: See Sodium to Treat

original_interventions:
KCl
Potassium Chloride


clinical_trial_age_range: 18 years or older

name: Zalutumumab in Combination With Chemo-Radiation in a Certain Type of Lung Cancer


clinical_trial_age_range: 13 years to 17 years

name: Pertussis and Meningitis C Concomitant Vaccination in Adolescents


clinical_trial_age_range: 75 years or older

name: Maintaining Immune and Mitochondrial Functions in Old Adults With SAfe Nutrition.


clinical_trial_age_range: 20 years or older

name: A Phase 1 Study Of Talazoparib, PARP Inhibitor, In Japanese Patients With Advanced Solid Tumors


name: Combination Therapy of Lenalidomide/Bortezomib/Dexamethasone and Panobinostat in Transplant Eligible New Diagnosed Multiple Myeloma (MM) Patients


name: Lymphoseek as Lymphoid Tissue Targeting Agent in Patients With Cancer of the Endometrium


name: R-ABVD vs ABVD-RT in Early Stage Hodgkin's Lymphoma


name: Feasibility Study of Adjuvant Treatment With S-1 and Oxaliplatin in Patients With Resectable Esophageal Cancer


clinical_trial_age_range: 18 years to 80 years

name: D-Dimer Determined Anticoagulation INTENSITY in Patients With Mechanical Valve Replacement


name: Oregovomab Plus Chemotherapy in Neo-adjuvant Setting in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer


name: Evaluation of Peginterferon Alfa-2b Monotherapy and Combination With Ribavirin in Participants With Acute Hepatitis C (P03552/MK-4031-137)


name: Assessment of Liver Cancer Response to TACE Using MultiHance-Enhanced MRI.


clinical_trial_primary_purpose: SCREENING

name: Effect of Controlled Hypotension on Cerebral Oxygen Saturation


clinical_trial_age_range: 18 years to 120 years

name: Sevelamer and Secondary Hyperparathyroidism in Chronic Kidney Disease


name: Sapanisertib and Ziv-Aflibercept in Treating Patients With Recurrent Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery


name: A Study Evaluating ClariVein With a Sclerosing Agent for the Treatment of Venous Insufficiency

original_interventions:
Sodium Tetradecyl Sulfate 1% Injection
Sodium Tetradecyl Sulfate 3% Injection


name: Multimodal Imaging Analysis During Treatment With Bevacizumab in Patients With Recurrent Glioblastoma


name: Ketamine for the Treatment of Refractory Status Epilepticus


name: A Study to Evaluate the Safety and Efficacy of Tocilizumab in Patients With Severe COVID-19 Pneumonia


name: Use of Trifluridine/Tipiracil and Oxaliplatin as Induction Chemotherapy for the Treatment of Resectable Esophageal or Gastroesophageal Junction (GEJ) Adenocarcinoma

original_conditions: Clinical Stage IIA Esophageal Adenocarcinoma AJCC v8

original_conditions: Clinical Stage III Esophageal Adenocarcinoma AJCC v8

original_conditions: Clinical Stage IVA Esophageal Adenocarcinoma AJCC v8

original_conditions: Pathologic Stage IIB Esophageal Adenocarcinoma AJCC v8

original_conditions: Pathologic Stage III Esophageal Adenocarcinoma AJCC v8

original_conditions: Pathologic Stage IIIA Esophageal Adenocarcinoma AJCC v8

original_conditions: Pathologic Stage IIIB Esophageal Adenocarcinoma AJCC v8

original_conditions: Pathologic Stage IVA Esophageal Adenocarcinoma AJCC v8

original_conditions: Clinical Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8

original_conditions: Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8

original_conditions: Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8

original_conditions: Pathologic Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8

original_conditions: Pathologic Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8

original_conditions: Pathologic Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8

original_conditions: Pathologic Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8

original_conditions: Pathologic Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8


name: Bortezomib and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Previously Untreated Symptomatic Multiple Myeloma


name: SOLIACS: Solian Solution in the Acute Setting


name: Ondissolve in the Prophylaxis/Rescue of Radiation Induced Nausea and Vomiting


name: An Expanded Access Program of Pegfilgrastim (Neulastim) in Participants With Non-Hodgkin's Lymphoma (NHL)


clinical_trial_age_range: 20 years to 65 years

name: The Effect of Combination of Mosapride and DPP-4 Inhibitor on Plasma Concentration of Incretin Hormones


name: CISH Inactivated TILs in the Treatment of NSCLC

original_conditions:
Metastatic Non Small Cell Lung Cancer
Stage IV Non-small Cell Lung Cancer


clinical_trial_age_range: 1 year to 18 years

name: Total Therapy XVII for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia and Lymphoma


clinical_trial_age_range: up to 22 years

name: A Phase II Trial of Poly-ICLC for Low-Grade Gliomas


clinical_trial_age_range: 30 years to 65 years

name: Pharmacokinetics and Dosimetry of Tc 99m Tilmanocept Following a Single Intravenous Dose Administration in Male and Female Subjects Diagnosed With Rheumatoid Arthritis (RA)


In Vitro Maturation of Human Eggs

clinical_trial_age_range: 21 years to 35 years

original_interventions:
FSH
Follicle Stimulating Hormone


clinical_trial_age_range: any age

name: An Observational Study to Describe EVUSHELD™ (Tixagevimab/Cilgavimab) Pre-exposure Prophylaxis in Real-world Setting in Japan


name: Antioxidant and Immunomodulator Properties of Viusid in Patients With Chronic Hepatitis C


clinical_trial_age_range: 18 years to 75 years

name: Neoadjuvant Sintilimab Plus Anlotinib Therapy in IB-IIIB Resectable Non-small Cell Lung Cancer


clinical_trial_age_range: 50 years or older

name: Pilot Study of X-82 in Patients With Wet AMD


clinical_trial_age_range: 18 years to 100 years

name: Efficacy Evaluation of VERU-111 for mCRPC in Patients Who Have Failed at Least One Androgen Receptor Targeting Agent

original_conditions: Metastatic Castration-resistant Prostate Cancer


name: Effects of Glucagon Like Peptide-1 on Haemodynamic Parameters


name: Study of CC-122 to Evaluate the Safety, Tolerability, and Effectiveness for Patients With Advanced Solid Tumors, Non-Hodgkin's Lymphoma, or Multiple Myeloma


name: Real-world Study of Trastuzumab Deruxtecan in Patients With Unresectable or Metastatic HER2-low Breast Cancer


name: Preventive Measures for Childhood-Onset Obsessive-Compulsive Disorder and Tic Disorders (PANDAS Subgroup)


clinical_trial_age_range: 32 months to 59 months

name: Synthetic Human Secretin in Children With Autism


name: SWOG-9451, Combination Chemo & RT For Patients With Stage III/Stage IV Cancer of the Hypopharynx or Tongue


name: Ketosis Impact on Signs & Symptoms of Schizophrenia and Bipolar disorderS


clinical_trial_age_range: 18 years to 65 years

name: Prochlorperazine Versus Acetaminophen, Aspirin, and Caffeine for the Treatment of Acute Migraine


clinical_trial_age_range: 18 years to 85 years

name: Dietary Strategies to Promote Muscle Protein Anabolism in the Elderly


name: Immunotherapy Combined With Chemoradiotherapy for First-line Treatment of Esophageal Squamous Cell Carcinoma（ChinECR）


clinical_trial_age_range: 18 years to 34 years

name: Improving Maternal and Child Health Through Prenatal Fatty Acid Supplementation


clinical_trial_age_range: up to 64 years

name: Evaluation of Danirixin (GSK1325756) Inhibition of CD11b Cell Surface Expression


clinical_trial_age_range: 18 years or older

name: Safety Study of Nebulized Sodium Nitroprusside in Adult Acute Lung Injury

original_conditions:
Acute Lung Injury
Acute Respiratory Distress Syndrome


clinical_trial_age_range: 18 years to 64 years

name: Topical Eflornithine for Pseudofolliculitis Barbae: Randomized Controlled Trial


name: Observation of Patients With Primary Pulmonary Hypertension Receiving Prescribed Ventavis Inhalation Therapy Regarding Safety and Efficacy for up to 4 Years


clinical_trial_age_range: 25 years to 55 years

name: Evaluation of the Efficacy of a New Supplement for Hair and Nails - in Vitro, Clinical, Subjective and Instrumental Study


clinical_trial_age_range: 25 years to 65 years

name: 28-Day Study of SAGE-718 on Functioning Capacity in Participants With Huntington's Disease


name: Prophylactic Administration of Alpha Blockers for Prevention of Urinary Retention in Males Undergoing Inguinal Hernia Repair Under Spinal Anaesthesia.


name: Chemotherapy and Radiation Therapy With or Without Metformin Hydrochloride in Treating Patients With Stage III Non-small Cell Lung Cancer


clinical_trial_age_range: 16 years to 90 years

name: Biological Tumor Infiltrating Lymphocytes Therapy With Immunotherapy for Colon and Rectum Cancer

original_conditions:
Colon Cancer
Colorectal Cancer


name: Nolpitantium Besylate In Patients With Ulcerative Colitis a Double-Blind, Placebo Controlled Efficacy and Safety Study


name: Diagnostic Value of Oral Prednisolone Test for Rheumatoid Arthritis


name: Single-dose Iloperidone Pharmacokinetics in Patients With Mild or Moderate Liver Disease, Compared to Healthy Volunteers


name: Cetuximab in Third Line for Mutant APC, TP53 and RAS Patients With Refractory Metastatic Colorectal Cancer


clinical_trial_age_range: 5 years to 15 years

name: Multicenter, Double-blind, Randomized, Placebo-controlled Study of Mometasone Furoate Nasal Spray in Pediatric Subjects With Perennial Allergic Rhinitis (Study P06332)


name: N-Acetyl-cysteine in Early Acute Respiratory Distress Syndrome


clinical_trial_age_range: 1 year to 25 years

name: Study of the Adverse Events and Change in Disease State of Pediatric Participants (and Young Adults Between the Ages of 18-25) With Relapsed/Refractory Aggressive Mature B-cell Neoplasms Receiving Subcutaneous (SC) Injections of Epcoritamab


name: Study to Evaluate Arthroplasty Specimens for Osteoarthritis of the Knee and Hip


name: Phase 1b/2 Study of BKM120 Plus Trastuzumab in Patients With HER2-positive Breast Cancer


clinical_trial_age_range: 18 years to 70 years

name: Reposition of Second Line Treatment in Chronic Immune Thrombocytopenia


name: Study to Evaluate Postoperative Analgesia in Subjects Undergoing Hemorrhoidectomy


clinical_trial_age_range: 12 years to 65 years

name: Efficacy and Safety Evaluation for the Treatment of Allergy Against Mites


clinical_trial_age_range: 18 years to 75 years

name: Mozobil for Autologous Stem Cell Mobilization


name: The Effects of Acute Administration of Bupropion on Neural Substrates Underlying Hedonic Capacity


clinical_trial_age_range: 18 years to 50 years

name: A Randomized, Placebo-Controlled Trial of Modafinil for Methamphetamine Dependence


clinical_trial_age_range: 13 years or older

name: A Multicenter Study To Determine Foscarnet Dose Response in HIV Infected Patients With PGL and/or Constitutional Disease


name: Neoadjuvant GTX With Chemoradiation for Pancreatic Cancer (Stage II/III)


name: Epacadostat, Idarubicin and Cytarabine (EIC) in AML


clinical_trial_age_range: up to 85 years

name: 64Cu/68Ga Labelled EB-ss-CPT PET/CT Scan in Colorectal Cancer


name: Study of Temsirolimus, Erlotinib and Cisplatin in Solid Tumors


name: Cetuximab and Bevacizumab as First-Line Therapy Followed By Combination Chemotherapy and Bevacizumab With or Without Cetuximab as Second-Line Therapy in Treating Patients With Stage IV Colorectal Cancer


name: Ultrasound vs. Surgical ESP Block With Bupivacaine-Dexmedetomidine in Lumbar Fusion Surgery


name: To Determine the Maximum Tolerated Dose of Oral CEP-37440 in Patients With Advanced or Metastatic Solid Tumors


clinical_trial_age_range: 21 years to 75 years

name: Intensive 7-day Treatment for PTSD Combining Ketamine With Exposure Therapy


name: CONCEPT: Comparison of Oxaliplatin vs Conventional Methods With Calcium/Magnesium in First-Line Metastatic Colorectal Cancer


name: Study Evaluating CMD-193 in Advanced Malignant Solid Tumors


name: Imaging of Coronary Plaques in Participants Treated With Evolocumab


name: Efficacy and Safety of Meteospasmyl® in Irritable Bowel Syndrome


Fexofenadine in Pruritic Skin Disease

clinical_trial_age_range: 12 years to 70 years


name: Using Antibiotics to Prevent Infections in Hemodialysis Patients During Catheter Placement


name: Effect of the Kv7-channel Opener Flupirtine on the Excitability of Human Peripheral Myelinated Axons in Vivo


name: Study of 5-Fluorouracil/Leucovorin/Oxaliplatin (FOLFOX) + Bevacizumab Versus 5-Fluorouracil/Leucovorin/Oxaliplatin/Irinotecan (FOLFOXIRI) + Bevacizumab as First Line Treatment of Patients With Metastatic Colorectal Cancer Not Previously Treated and With Three or More Circulating Tumoral Cells


name: Safety, Tolerability, and Anti-Tumor Activity of AFM24 in Combination With SNK01 in Subjects With Advanced/Metastatic EGFR-Expressing Cancers

original_conditions: Squamous Cell Carcinoma of Head and Neck


name: Study of Gemcitabine Chemoradiation and TNP-470 Patients Locally Advanced, Nonmetastatic Adenocarcinoma of Pancreas


name: Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial Cancer

original_conditions: Cancer Tumor


clinical_trial_age_range: 10 years to 18 years

name: A Study to Evaluate Efficacy, Safety, and Tolerability of Alemtuzumab in Pediatric Patients With RRMS With Disease Activity on Prior DMT


name: Rituximab (Rtx) + Tafasitamab in Combination With Allogeneic NK Cells for Treatment of Relapsed/Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)

original_conditions:
Chronic Lymphocytic Leukemia
Small Lymphocytic Lymphoma

original_conditions: Primary Mediastinal Large B Cell Lymphoma


name: Comparison of Oral Gabapentin and Pregabalin in Postoperative Pain Control After Photorefractive Keratectomy


name: Irinotecan for Previously Treated, Advanced, Non-Small Cell Lung Cancer


clinical_trial_age_range: 45 years to 70 years

name: Saturated Fatty Acids and HDL Metabolism


clinical_trial_age_range: 18 years or older

name: Intravenous Methadone in Perioperative Acute and Chronic Management in Chinese Adult Cardiac Surgical Patients


clinical_trial_age_range: 9 years to 17 years

name: A Study of Duloxetine (LY248686) in Japanese Children and Adolescents With Depressive Disorder


name: Trial of Single Protein Encapsulated Doxorubicin, SPEDOX-6 in Advanced Malignancies


clinical_trial_age_range: 19 years to 75 years

name: Docetaxel in Non Small Cell Lung Cancer (NSCLC)

original_interventions: Docetaxel docetaxel


clinical_trial_age_range: up to 17 years

name: Catheter-Related Early Thromboprophylaxis With Enoxaparin (CRETE) Trial


name: Gemcitabine and ISIS 2503 in Treating Patients With Advanced or Metastatic Cancer of the Pancreas


name: Multiple Dose Escalation Trial Of PF-04603629 Given To Subjects With Type 2 Diabetes Mellitus


name: Tumescent Antibiotic Delivery for Prevention of Surgical Site Infection


clinical_trial_age_range: 20 years or older

name: Clinical Study to Evaluate Efficacy and Safety of TAK-385 40 mg Compared With Leuprorelin in Patients With Endometriosis


clinical_trial_age_range: up to 48 hours

name: Glucagon in the Treatment of Hypoglycemia in Newborn Infants of Diabetic Mothers


name: Oxaliplatin/Irinotecan/Bevacizumab Followed by Docetaxel/Bevacizumab in Inoperable Locally Advanced or Metastatic Gastric Cancer Patients


clinical_trial_age_range: 18 years to 60 years

name: A Study of the Efficacy and Safety of Ziprasidone in Patients With Acute Exacerbation of Schizophrenia or Schizoaffective Disorder

original_conditions:
Schizoaffective Disorder
Schizophrenia


clinical_trial_age_range: 21 years or older

name: High Relaxivity Contrast Agent for Cardiac MR in the Myocardial Scar Assessment


name: Clofazimine- and Rifapentine-Containing Treatment Shortening Regimens in Drug-Susceptible Tuberculosis: The CLO-FAST Study


name: Emend for Multiple-day Emetogenic Chemotherapy


name: SU5416 in Treating Patients With Advanced or Recurrent Cancer of the Head and Neck


clinical_trial_age_range: 18 years to 80 years

name: A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNFα Inhibitor


name: Bendamustine, Gemcitabine and Vinorelbine (BeGEV) as Induction Therapy in Relapsed/Refractory Hodgkin's Lymphoma Patients


clinical_trial_age_range: 18 years to 99 years

name: Antineoplaston Therapy in Treating Patients With Stage IV Pancreatic Cancer


name: Changes in MTX-PG Concentrations During Subcutaneous MTX Therapy in Patients With Rheumatoid Arthritis(COSMOS Study)

original_interventions: MTX Methotrexate


clinical_trial_age_range: 18 years to 75 years

name: Study of CM313 in Subject With IgA Nephropathy


name: A Phase II Study of Pomalidomide in Myelofibrosis With Myeloid Metaplasia

original_conditions:
Myelofibrosis
Myelofibrosis With Myeloid Metaplasia


name: A SMART Design to Improve Sleep Disturbance in Adolescents With Neurodevelopmental Disorders

original_conditions: Attention Deficit Hyperactivity Disorder


clinical_trial_age_range: 60 years or older

name: Anti-CD38 Antibody Treating Elderly Patients With Primary Immune Thrombocytopenia (ITP)


name: A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Bevacizumab in Adult Participants With Ovarian Cancer


name: Simvastatin Metabolism as a Test for CD Activity (IRB 15-007568]


name: A Study To Investigate GW274150 Or Prednisolone In Rheumatoid Arthritis Taken Repeatedly For 28 Days.


clinical_trial_age_range: 18 years to 100 years

name: A Window of Opportunity Study to Investigate Mechanisms of Actions of Novel Therapeutic Agents in Patients With Resectable Solid Tumor Malignancies


clinical_trial_age_range: 20 years to 59 years

name: Dalfampridine for Imbalance in Multiple Sclerosis


name: Pharmacokinetic Study of Pitavastatin and Ritonavir-Boosted Darunavir or Efavirenz


clinical_trial_age_range: 3 years to 12 years

name: Prepubertal Children With Growth Failure Associated With Primary Insulin-Like Growth Factor-1 (IGF-1) Deficiency


clinical_trial_age_range: 3 years to 16 years

name: Growth Hormone Therapy in Osteogenesis Imperfecta


clinical_trial_age_range: 21 years to 72 years

name: Busulfan, Melphalan, Fludarabine and T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation Followed by Post Transplantation Donor Lymphocyte Infusions


clinical_trial_age_range: 18 years or older

name: Breath Monitoring of Propofol (Observational Study)


clinical_trial_age_range: 18 years to 69 years

name: Memantine and Intensive Speech-Language Therapy in Aphasia


clinical_trial_age_range: 18 years to 45 years

name: Drug Interactions Trial of Methoxyethyl Etomidate Hydrochloride


name: Safety and Efficacy Study of Epcoritamab in Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia and Richter's Syndrome


name: S0501 Fludarabine, Melphalan, and Donor Stem Cell Transplant Followed By Tacrolimus and Methotrexate in Treating Patients for Relapsed Lymphoma


name: Enzalutamide With Ribociclib in Treating Patients With Metastatic Castrate-Resistant, Chemotherapy Naive Prostate Cancer That Retains Retinoblastoma Expression

original_conditions: Prostate Carcinoma Metastatic in the Bone


clinical_trial_age_range: up to 18 years

name: Efficacy of Human Coronavirus-immune Convalescent Plasma for the Treatment of COVID-19 Disease in Hospitalized Children


name: A Study to Find a Suitable Dose of BI 765883 and to Test Whether it Helps People With Advanced Pancreatic Cancer When Taken Alone or Together With Chemotherapy


name: Ivabradine Effects in Cardiogenic Shock Requiring Inotropic Support


name: Topotecan, Cisplatin and Bevacizumab for Recurrent/Persistent Cervical Cancer


name: The Effect of Carvedilol VS Endoscopic Therapy in Primary Prophylaxis of High-risk Esophageal Gastric Variceal Bleeding


name: A Study of WX390 in Patients With Advanced Solid Tumors With PIK3CA Mutations


clinical_trial_age_range: 18 years to 65 years

name: The Effect on Androxal Versus Androgel on Morning Testosterone in Men With Secondary Hypogonadism (Low Testosterone)


clinical_trial_age_range: 0 years to 6 years

name: Observational Study of Safety and Tolerability of Levemir™ FlexPen™ (Insulin Detemir) in the Treatment of Type 1 and Type 2 Diabetes Mellitus

original_conditions:
Diabetes
Diabetes Mellitus, Type 2


clinical_trial_age_range: 18 years to 60 years

name: Study to Evaluate the Effects of a Cytochrome P450 2C19 Inhibitor on the Pharmacokinetics of Miricorilant


name: Chemotherapy Combined with ICIs in First-line Alectinib Failed Patients with ALK-rearranged NSCLC


name: A Study of SHR-1210 in Combination With Capecitabine + Oxaliplatin or Apatinib in Treatment of Advanced Gastric Cancer


clinical_trial_age_range: 18 years to 70 years

name: Adebrelimab ±Induction Chemotherapy Followed by Concurrent Chemoradiotherapy for Unresectable Locally Advanced ESCC


name: Tranexamic Acid in Surgery of Advanced Ovarian Cancer


name: Sedation During Endoscopy Using Remimazolam: Efficacy in a Novel Exploration


clinical_trial_age_range: 18 years to 80 years

name: A Swiss Study With Atorvastatin in Hyperlipidemic Patients Measuring LDL-Cholesterol


name: Study Comparing Orteronel Plus Prednisone in Participants With Metastatic Castration-Resistant Prostate Cancer.


name: Vorinostat and Lenalidomide After Autologous Stem Cell Transplant in Treating Patients With Multiple Myeloma

original_conditions:
Multiple Myeloma
Plasma Cell Neoplasm


Methylsulfonylmethane on Knee Laxity

clinical_trial_age_range: 18 years to 30 years


name: Mistletoe Therapy in Primary and Recurrent Inoperable Pancreatic Cancer


name: Natalizumab (BG00002, Tysabri) Study in Japanese Participants With Relapsing-Remitting Multiple Sclerosis (RRMS)


clinical_trial_age_range: 2 years to 18 years

name: Different Reversal Agents in Pediatric Day-case Cancer Surgery


name: Retrospective Chart Review Study to Assess Characteristics, Treatment Outcomes and Resource Use of Adults Hospitalized for CAP and CSSTi Treated With Zinforo in Multiple Countries

original_conditions: Complicated Skin and Soft Tissue Infection


name: A Study of Denufosol Tetrasodium Intravitreal Injection in Subjects With Post Cataract Extraction Macular Edema


name: Phase I/II Comparison of Efficacy and Safety of BIBF 1120 and Sorafenib in Patients With Advanced Hepatocellular Carcinoma


clinical_trial_age_range: any age

name: Oxandrolone for the Treatment of Bone Marrow Aplasia in Fanconi Anemia


name: Neoadjuvant/Adjuvant Trial of Darovasertib in Ocular Melanoma


name: Development of a Metabolic Assessment Tool for Chronic Kidney Disease


name: Utility of Olanzapine in the Treatment of Opioid Withdrawal in the ED


name: A Phase I Study of Oral Asciminib (ABL001) in Patients With CML or Ph+ ALL

original_conditions: Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia


name: Clinical Outcomes With Ceftolozane-tazobactam for MDR Pseudomonas Infections


name: A Study to Evaluate Denosumab in Young Patients With Primary Breast Cancer


name: Better Evidence for Selecting Transplant Fluids


clinical_trial_age_range: 16 years or older

name: Recombinant Human C1 Inhibitor for the Treatment of Acute Attacks in Patients With Hereditary Angioedema


name: Prevention of Sagopilone-induced Neurotoxicity With Acetyl-L-Carnitine (ALC)

original_interventions: ALC Acetyl-L-Carnitine


clinical_trial_age_range: 1 year to 3 years

name: Oral Immunotherapy for Young Children With Peanut Allergy - Small Children OIT


name: Combination Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer


name: Understanding the Metabolic and Functional Derangement of Primary Mitral Regurgitation: a Feasibility Study Using Carbon 11(C-11) Acetate Cardiac Positron Emission Tomography Magnetic Resonance Imaging (PET-MRI)


clinical_trial_age_range: 40 years or older

name: Feasibility and Safety of Immunoglobulin (Ig) Treatment in COPD Outpatients With Frequent Exacerbations: Pilot Study 1

original_conditions: Chronic Obstructive Pulmonary Disease (COPD)


name: Stem Cell Mobilization With Plerixafor in Diabetic vs Control Subjects


clinical_trial_age_range: 50 years or older

name: A Clinical Effectiveness Study Examining the Efficacy and Safety of ONS-5010 in Subjects With Neovascular Age-related Macular Degeneration (AMD)


clinical_trial_age_range: 18 years to 50 years

name: Galantamine to Enhance Cognitive Behavioral Therapy for Cocaine Abuse


clinical_trial_age_range: 18 years or older

name: COBRA-Slim With or Without Fast Access to TNF Blockade for Remission Induction in Early RA


name: Study of the Efficacy and Safety of RsqVD Combination Therapy for Patients With Newly Diagnosed Multiple Myeloma


clinical_trial_age_range: 18 years to 75 years

name: BC3402 in Combination With Durvalumab in Patients With Advanced Hepatocellular Carcinoma


clinical_trial_age_range: 16 years to 80 years

name: Safety and Efficacy of Lithium Carbonate in Patients With Spinocerebellar Ataxia Type 3

original_conditions:
Machado Joseph Disease
Spinocerebellar Ataxia Type 3


clinical_trial_age_range: 20 years to 70 years

name: The Effect of Rosiglitazone on Ischemia-reperfusion-injury Using Annexin A5 Scintigraphy.


name: Erlotinib in Patients With Resected, Early Stage NSCLC With Confirmed Mutations in the EGFR


clinical_trial_age_range: 19 years to 55 years

name: PK Interaction Between Rifapentine or Rifampicin and a Single Dose of TMC207 in Healthy Subjects (TMC207-CL002)


clinical_trial_age_range: 9 years to 22 years

name: Hypothalamic Obesity Following Craniopharyngioma Surgery: A Pilot Trial of Combined Metformin and Diazoxide Therapy


name: Non-inferiority Trial on Monoclonal Antibodies in COVID-19


name: Nab-paclitaxel as Second-line Therapy in Locally Advanced or Metastatic Squamous Lung Cancer


name: Clinical Study on Efficacy and Safety of Hetrombopag in the Preoperative Patients of Thrombocytopenia


name: Break-through Infection Following Mpox vaccinatIon


clinical_trial_age_range: 6 years to 55 years

name: Early Markers of Disease and Response to Therapy


clinical_trial_age_range: 18 years to 35 years

name: Effects of a Thermogenic Dietary Supplement on Metabolic, Hemodynamic, and Mood Responses


name: The Randomised Epidural Analgesia in Term Delivering Women Trial (TREAT)


clinical_trial_age_range: 19 years or older

name: Predictive Biomarkers in Patients With Advanced Hepatocellular Carcinoma Treated With Systemic Therapy


name: Study to Evaluate the Effects of Two Doses of Seladelpar (MBX-8025) in Subjects With Primary Biliary Cirrhosis (PBC)


clinical_trial_age_range: 18 years to 80 years

name: Beryllium Infliximab Study: Clinical Interventional Trial

original_conditions:
Berylliosis
Beryllium Disease


name: Pazopanib Hydrochloride With or Without Ascorbic Acid in Treating Patients With Kidney Cancer That Is Metastatic or Cannot Be Removed by Surgery

original_conditions: Metastatic Clear Cell Renal Cell Carcinoma


clinical_trial_age_range: 60 years or older

name: Feasibility and Efficacy of Dietary Interventions for Older Adults With Subjective Cognitive Decline


clinical_trial_age_range: any age

name: Neurobiology of Opioid Dependence: 5 - 5


name: A Study of Combination of Temsirolimus (Torisel®) and Pegylated Liposomal Doxorubicin (PLD, Doxil®/Caelyx®) in Advanced or Recurrent Breast, Endometrial and Ovarian Cancer


clinical_trial_age_range: 5 years or older

name: Reduction of EArly mortaLITY in HIV-infected Adults and Children Starting Antiretroviral Therapy


name: Teicoplanin in Treating Septicemia in Patients Who Are Receiving Chemotherapy Through a Central Venous Catheter


name: A Study Comparing AZD2014 vs Everolimus in Patients With Metastatic Renal Cancer


name: Use of Santyl Within an Accountable Care Organization


clinical_trial_age_range: 20 years to 50 years

name: Levels of Anti-Mullerian Hormone (AMH) During Ovarian Stimulation With Gonadotropins


clinical_trial_age_range: 18 years to 30 years

name: Dopamine and Muscle Function in the Heat


name: Immunological Effects of Vitamin D Replacement Among Black/African American Prostate Cancer Patients


clinical_trial_age_range: 19 years to 75 years

name: Eptinezumab as an Adjunct to Standard of Care for Migraine in an Acute Emergency Context


name: Safety Study of Autologous Dendritic Cells Injected Into the Prostate After Cryoablation for Advanced Prostate Cancer


clinical_trial_age_range: 18 years to 65 years

name: Evaluating the Efficacy of Adjunctive Minocycline for the Treatment of Bipolar Depression

original_conditions:
Bipolar Depression
Bipolar Disorder


clinical_trial_age_range: 18 years or older

name: A Randomized Trial of Interim Methadone and Patient Navigation Initiated in Jail


name: Abiraterone Acetate in Molecular Apocrine Breast Cancer


name: A Study of Participant Satisfaction and Safety With Subcutaneously Administered Trastuzumab (Herceptin) in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Early Breast Cancer


name: Capecitabine and Radiation Therapy With or Without Panitumumab in Treating Patients With Advanced Rectal Cancer


clinical_trial_age_range: up to 21 years

name: Risk-Adapted Focal Proton Beam Radiation and/or Surgery in Patients With Low, Intermediate and High Risk Rhabdomyosarcoma Receiving Standard or Intensified Chemotherapy

original_interventions:
Etoposide
Etoposide Phosphate


name: Safety and Efficacy Study of Umbilical Cord/Placenta-Derived Mesenchymal Stem Cells to Treat Type 2 Diabetes


clinical_trial_age_range: 18 years to 84 years

name: A Study to Look at the Effect MEDI0382 Has on Blood Sugar in People With Type 2 Diabetes and Kidney Problems and Also to Check That MEDI0382 is Well Tolerated


clinical_trial_age_range: 55 years to 95 years

name: A Pilot of Methylphenidate in Mild Cognitive Impairment and Dementia Participants.

original_interventions: Methylphenidate Extended Release Oral Capsule


clinical_trial_age_range: 18 years to 45 years

name: Effectiveness of OZ439 Against Early Plasmodium Falciparum Blood Stage Infection in Healthy Volunteers


clinical_trial_age_range: 19 years to 40 years

name: Proof of Concept Creatine Supplementation for Homocystinuria Study


clinical_trial_age_range: 6 years or older

name: Study to Provide Continued Access to Treatment for Patients Completing a Previous Trial With Efanesoctocog Alfa


name: IV Cocaine Abuse: A Laboratory Model - 1


PREGNANT Short Cervix Trial

clinical_trial_age_range: 15 years to 45 years


name: A Phase I Clinical Study of Oral CP-4126 in Patients With Advanced Solid Tumour


name: A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Mellitus


name: Spironolactone in Patients With Single Ventricle Heart


name: Evaluation of the iStent Versus Two Ocular Hypotensive Agents in Patients With Primary Open-angle Glaucoma (POAG)


clinical_trial_age_range: 20 years to 70 years

name: Inhibition of Disease Progression in Hepatitis C-infected Patients With Compensated Liver Cirrhosis (P03811) (COMPLETED)

original_interventions: Rebetol ribavirin


name: Post Marketing Surveillance Study to Evaluate the Tolerability of Rebif® New Formulation in Patients With Relapsing Multiple Sclerosis in an Australian Clinical Setting.

original_interventions:
Interferon beta-1a
Rebif


name: Ketamine for Acute Migraine in the Emergency Department


clinical_trial_age_range: 50 years or older

name: Extension Study of rhuFab V2 in Subjects With Neovascular Age-Related Macular Degeneration (AMD)

original_interventions:
ranibizumab
rhuFab V2


clinical_trial_age_range: 18 years to 75 years

name: Safety and Efficacy of POL6326 for Mobilization/Transplant of Sibling Donor in Patients With Hematologic Malignancies

original_conditions: Adult Acute Lymphoblastic Leukemia in Remission


clinical_trial_age_range: 50 years to 90 years

name: Safety and Tolerability of AZD0530 (Saracatinib) in Alzheimer's Disease


name: A Dose-Ranging Study of the Effect of Glycopyrrolate in Subjects With Axillary Hyperhidrosis


name: Study to Evaluate Menses Induction in Women Administered Proellex


clinical_trial_age_range: 18 years to 130 years

name: To Assess the Pharmacokinetics, Safety and Tolerability of Selumetinib in Patients With Hepatic Impairment and Healthy Subjects


Infliximab Top-down in Pediatric Crohn

clinical_trial_age_range: 3 years to 17 years


clinical_trial_age_range: 1 year to 30 years

name: A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

original_conditions: Recurrent B Acute Lymphoblastic Leukemia


name: Dolutegravir-Lamivudine as Dual Therapy in naïve HIV-Infected Patients With Documented M184V Mutation:A Pilot Study


name: A Study of Vascular Endothelial Growth Factor (VEGF) Inhibition in Patients With Unilateral Upper Extremity Lymphedema Following Treatment for Cancer


clinical_trial_age_range: 1 year to 6 years

name: Autonomous Nervous System Regulated Paediatric Anaesthesia With Dexmedetomidine or Placebo


clinical_trial_age_range: 18 years to 65 years

name: An Open Label Trial of Memantine in the Treatment of Bulimia Nervosa and Body Dysmorphic Disorder


clinical_trial_age_range: 18 years or older

name: Cancer Immunotherapy GSK1572932A as Adjuvant Therapy for Patients With Tumor-antigen-positive Non-Small Cell Lung Cancer


name: Digital Monitoring of Self-reported Symptoms by Patients Treated With Cabozantinib Plus Nivolumab for Advanced Clear-cell Renal Carcinoma


name: Phase II Study of Liposomal Irinotecan for Advanced Refractory Gastric Cancer


name: Phase II Study of Irinotecan HCI for Recurrent Anaplastic Astrocytomas, Mixed Malignant Gliomas, and Oligodendrogliomas

original_conditions: Astrocytoma Oligodendroglioma


clinical_trial_age_range: up to 12 months

name: Double Ligation and Topical Silver Nitrate


name: Clinical and Economic Burden of Uncontrolled Epilepsy: Analyses From a Medicaid Database and a Private Health Plan Database


clinical_trial_age_range: 10 years or older

name: Antioxidant Therapy to Reduce Inflammation in Sickle Cell Disease


name: Botox in the Healing of Surgical Wounds of the Neck


name: Study to Evaluate the Efficacy and Safety of Lenalidomide in the Treatment of Complex Regional Pain Syndrome Type 1


clinical_trial_age_range: 15 years to 75 years

name: Standard Idarubicin and Cytarabine for the Treatment of Acute Myeloid Leukemia (AML)

original_conditions:
AML
Acute Myeloid Leukemia


name: The Effect of Valacyclovir on the Detection of HIV From Genital Herpes Lesions in HIV-Infected Patients


clinical_trial_age_range: 20 years to 79 years

name: Comparison of the Blood Sugar Lowering Effect of Biphasic Insulin Aspart 30 and Insulin Glargine Both Combined With Metformin and Glimepiride in Chinese and Japanese Subjects With Type 2 Diabetes New to Insulin Treatment


name: Study of the CHK1 Inhibitor BBI-355, an ecDNA-directed Therapy (ecDTx), and the RNR Inhibitor BBI-825, in Subjects With Tumors With Oncogene Amplifications


clinical_trial_age_range: 18 years to 40 years

name: Effectiveness of Homeopathic Treatment in Female Infertility


neoadjuvant_thymic Epithelial Tumor

clinical_trial_age_range: 19 years or older


name: A Test and Treat Strategy in New HIV Diagnosis.


name: Efficacy and Safety Study of Lipid-Lowering Effects of XueZhiKang (XZK) in Patients With Hyperlipidemia

original_interventions: XZK XueZhiKang


name: Colchicine for Reduction of Periprocedural Myocardial Injury in Percutaneous Coronary Intervention


clinical_trial_age_range: 45 years to 60 years

name: Efficacy and Tolerability Study of Progesterone Vaginal Tablets (Endometrin®) in Menopausal Women Treated by Estrogen


name: A Study of NX-019 in Patients with Advanced, Epidermal Growth Factor Receptor (EGFR) Mutant Cancer


clinical_trial_age_range: 40 years or older

name: Probucol for Symptomatic Intracranial and Extracranial Artery Stenosis


name: Respimat® Combivent Trial in Chronic Obstructive Pulmonary Disease (COPD)


clinical_trial_age_range: 12 years to 64 years

name: Pharmacokinetics of Gepotidacin Tablets in Adults and Adolescents Subjects


clinical_trial_age_range: 60 years to 90 years

name: Mechanisms of Antidepressant Non-Response in Late-Life Depression


name: CKD-828 Primary Hypertension Trial(Dose-selection)


name: Ruxolitinib With Radiation and Temozolomide for Grade III Gliomas and Glioblastoma


name: Phase 1/2a Study of SQ3370 in Patients With Advanced Solid Tumors


clinical_trial_age_range: 2 months to 15 years

name: Randomized Trial Comparing 3 Routes of Delivering Lorazepam to Children.


clinical_trial_age_range: 18 years to 99 years

name: Open-label Extension (OLE) Study to Assess Safety and Efficacy of Evolocumab


Tepotinib Hepatic Impairment Trial

clinical_trial_age_range: 18 years to 75 years


clinical_trial_age_range: 18 years to 70 years

name: Continuing Lamivudine Versus Switching to Entecavir in Patients Who Achieved Undetectable Hepatitis B Virus DNA


name: Extension Study Evaluating Etanercept in Ankylosing Spondylitis


clinical_trial_age_range: 50 years or older

name: Evaluation the Pharmacokinetics, Safety, Tolerability of BCD-021 in Patients With Neovascular Age-related Macular Degeneration


name: Concurrent vs. Sequential Sipuleucel-T & Abiraterone Treatment in Men With Metastatic Castrate Resistant Prostate Cancer

original_conditions:
Castration-resistant Prostate Cancer
Hormone Refractory Prostate Cancer


name: Letetresgene Autoleucel Engineered T Cells in NY-ESO -1 Positive Advanced Non-Small Cell Lung Cancer (NSCLC)


clinical_trial_age_range: 6 years to 18 years

name: Effect of Melatonin in Pediatric Hemodialysis Patients


clinical_trial_age_range: up to 18 years

name: Glivec in Pediatric Chronic Myeloid Leukemia (CML)


clinical_trial_age_range: 18 years to 65 years

name: Study of Brexpiprazole as Adjunctive Treatment of Irritability in Patients With Major Depressive Disorder and an Inadequate Response to Antidepressant Therapy


clinical_trial_age_range: 60 years or older

name: SSAT064: Pharmacokinetics of Abacavir/Lamivudine/Dolutegravir in HIV Patients of 60 Years and Over


clinical_trial_age_range: 18 years to 55 years

name: Evaluating the Safety and Immunogenicity of PENNVAX®-GP DNA Vaccine and IL-12 Plasmid, Delivered Via Intradermal or Intramuscular Electroporation in Healthy, HIV-Uninfected Adults


clinical_trial_age_range: 18 years to 38 years

name: Comparison of Clomiphene Citrate and Gonadotropins in Ovulation Induction Cycles


clinical_trial_age_range: 18 years or older

name: Evaluate the Efficacy and Safety of Edoxaban on Prevention of Catheter-related Thrombosis (CRT) in Cancer Patients


name: Gemcitabine Plus Rapamycin Versus Gemcitabine to Treat Advanced Soft Tissue Sarcoma


name: T Cell Receptor Based Therapy of Metastatic Colorectal Cancer


clinical_trial_age_range: 18 years to 40 years

name: Premature Luteinization Prevention by GnRH Antagonist in Patients Undergoing IUI


name: Contrast-Enhanced Ultrasound in Diagnosing Patients With Liver Cancer Undergoing Yttrium-90 Radioembolization


name: AImmune - Artificial Intelligence Algorithm for Identification of Immunogenic Neoepitopes of Cancer to Predict and Boost Patient's Response to Immunotherapies.


name: Efficacy and Safety of 4.5mg PEG-rhG-CSF Per Cycle in Preventing Neutropenia After Intensive Chemotherapy for Breast Cancer


name: RCT Comparing ESPB Solutions in Breast Surgery


clinical_trial_age_range: any age

name: Randomized Clinical Trial of Intravitreal Bevacizumab Versus Intravitreal Bevacizumab Combined With Losartan in the Treatment of Diabetic Macular Edema


name: Drug Interaction Study of Pyronaridine-artesunate & Metoprolol, & Redosing Study of Pyronaridine-artesunate


name: Study on the Efficacy and Safety of Berberine, Minocycline, Esomeprazole, and Colloidal Bismuth Quadruple Therapy in the Initial Treatment of Helicobacter Pylori.


name: Study to Assess Safety, Tolerability and Efficacy of Incremental Doses of MGB-BP-3 in Patients With CDAD


clinical_trial_age_range: 18 years to 57 years

name: Pharmacokinetic Study of Vivitrol in Healthy Participants


clinical_trial_age_range: 16 years or older

name: Pharmacokinetic Study to Evaluate Double-Dose Levonorgestrel Emergency Contraception in Combination With Efavirenz-Based Antiretroviral Therapy or Rifampicin-Containing Anti-Tuberculosis Therapy


clinical_trial_age_range: 5 years to 99 years

name: Flecainide for Catecholaminergic Polymorphic Ventricular Tachycardia


name: A Trial Assessing Several Schedules of Oral S-1 in Combination With a Fixed Dose of Oxaliplatin and Irinotecan


name: Gemcitabine Plus Supportive Care in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer


name: Treatment Patterns of Neratinib in HER2+ EBC in China


clinical_trial_age_range: 18 years to 120 years

name: Irinotecan in Treating Patients With Metastatic or Inoperable Thyroid Cancer


name: GSK2251052 in the Treatment of Complicated Intra-abdominal Infections


name: A Study of Herceptin (Trastuzumab) in Combination With a Taxane in Participants With HER2-Positive Breast Cancer Who Relapsed After (Neo)Adjuvant Herceptin Treatment


name: A Study of SER-155 to Treat Diarrhea in People on Immunotherapy


name: XH001 Combination With Immunocheckpoint Inhibitor and Chemotherapy for Patients With Resected Pancreatic Cancer


STAAR-1 Clinical Study

original_conditions:
Chronic Kidney Disease
Chronic Renal Insufficiency


clinical_trial_age_range: 18 years to 90 years

name: A Phase I/II Dose Escalation and Expansion Study of BST-236 Plus Venetoclax in Patients With Unfit Newly Diagnosed AML


name: An Open-label, Phase 1/2 Trial of Gene Therapy 4D-310 in Adults With Fabry Disease


name: ALPN-101 (Acazicolcept) in Systemic Lupus Erythematosus


name: Dimethyl Fumarate (DMF, Tecfidera®) Persistence in RR-MS Patients Included in the French Patient Support Program OroSEP


name: Safety, Efficacy, and Pharmacokinetic Behavior of Leuprolide Mesylate (LMIS 25 mg) in Subjects With Prostate Cancer


name: Probiotic Treatment in Adult Obsessive-Compulsive Disorder


clinical_trial_age_range: 12 months to 23 months

name: A Study of 2 Doses of VAQTA™ in Healthy Children 12 to 23 Months of Age (V251-069)


clinical_trial_age_range: 18 years to 80 years

name: Trial of Alvimopan in Major Spine Surgery


name: Impact of Nicotinamide Riboside (NR) on Kidney Function in Patients Undergoing Cardiac Surgery


name: Mechanism of SGLT2 Inhibition in the Kidney


name: Efficacy Study of Oral Sapacitabine to Treat Acute Myeloid Leukemia in Elderly Patients

original_interventions: Sapacitabine sapacitabine


clinical_trial_age_range: 18 years to 60 years

name: A Study to Evaluate the Safety, Tolerability, Cellular Kinetics, and Pharmacodynamics of P-CD19CD20-ALLO1 in Participants With Multiple Sclerosis


clinical_trial_age_range: 18 years to 75 years

name: A Study of Adebrelimab Combined With Chemoradiotherapy in the Treatment of Esophageal Small Cell Carcinoma


clinical_trial_age_range: 18 years to 79 years

name: Rapid P2Y12 Receptor Inhibition Attenuates Inflammatory Cell Infiltration in Thrombus Aspirated From the STEMI Patients


clinical_trial_age_range: 18 years to 70 years

name: The Optimal Dose of Mannitol for Intraoperative Brain Relaxation During the Operation of Aneurysmal Subarachnoid Hemorrhage


name: HDAC Inhibitor Combination with Chemoimmunotherapy in the Neoadjuvant Treatment of PMMR Locally Advanced Colon Cancer


name: Vemurafenib Combined With Whole Brain Radiation Therapy or Radiosurgery in Patients With BRAF Mutation-Positive Melanoma and Brain Metastases


name: Reduction of Microembolism After the Intervention Surgery of Intracranial Aneurysms by Administration of Tirofiban


name: Optimized Treatment of Peginterferon Alfa 2a/2b in Anti-virus Treatment Naive Patients With HBV Related Liver Fibrosis


name: Study of CS-1008 in Patients With Advanced Solid Malignancies and Lymphomas (Without Leukemic Component)


name: Trastuzumab or Lapatinib Ditosylate in Treating Women With Early Breast Cancer


clinical_trial_age_range: 50 years to 85 years

name: Salsalate in Patients Mild to Moderate Alzheimer's Disease


name: S0722: Everolimus in Treating Patients With Pleural Malignant Mesothelioma That Cannot Be Removed By Surgery


clinical_trial_age_range: 18 years to 65 years

name: Sjogrens Syndrome Measured by Ultrasound


name: Atezolizumab+Bevacizumab+SBRT in Unresectable HCC


name: A Dose Response Study of E6011 in Participants With Rheumatoid Arthritis Inadequately Responding to Methotrexate


name: A Study for the Neoadjuvant Treatment of Breast Cancer


name: Study of VAL-083 in Patients With MGMT Unmethylated, Bevacizumab-naive Glioblastoma in the Adjuvant or Recurrent Setting

original_conditions:
GBM
Glioblastoma
Glioblastoma Multiforme


name: Outcomes of Injections in Patients Waiting for Total Knee Replacement


name: Tracing Changed Production of Red Blood Cells


name: A Study of Pembrolizumab in Patients With Malignant Peripheral Nerve Sheath Tumor (MPNST), Not Eligible for Curative Surgery

original_conditions: Malignant Peripheral Nerve Sheath Tumour (MPNST)


name: Two Phase Extension Trial of SP668 to Investigate the Safety and Tolerability of Sustained Release Fesoterodine in Subjects With Overactive Bladder: a Double-Blind Phase Followed by an Open-Label Extension Phase


name: Evaluation of SPH3127 in Patients With Mild-to-Moderate Ulcerative Colitis


name: Dose Escalation and Expansion Study of GSK525762 in Combination With Fulvestrant in Participants With Hormone Receptor-positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Advanced or Metastatic Breast Cancer


clinical_trial_age_range: 19 years or older

name: Trial of Trametinib and Ponatinib in Patients With KRAS Mutant Advanced Non-Small Cell Lung Cancer

original_interventions:
Trametinib 0.5 mg
Trametinib 2 mg

original_interventions:
Ponatinib 15 MG
Ponatinib 30 MG


name: Efficacy of D-allulose on Weight and Fat Loss and Insulin Resistance in Non-diabetic Obese Subjects


name: Study Comparing the Affect of Bifeprunox Vs Olanzapine on Weight During the Treatment of Outpatients With Schizophrenia.


clinical_trial_age_range: 18 years or older

name: EdOxaban in fRagIle Patients With Percutaneous Endoscopic GAstrostoMy and atrIal fIbrIllation


name: Etanercept for the Treatment of Chronic Urticaria


clinical_trial_age_range: 18 years to 77 years

name: A Phase 3 Study of BMS-477118 in Combination With Metformin in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise


name: Lenalidomide and Gemcitabine as First-line Treatment in Patients With Pancreatic Cancer


name: Serum Tryptase Levels During Cardiac Surgery, Diagnosis and Treatment Decisions for Allergic Reactions


name: Lenalidomide and Darbepoetin in Low-Intermediate Risk Myelodysplastic Syndrome (MDS)


clinical_trial_age_range: 45 years to 65 years

name: Open-Label Study of Vaginal AZU-101 in Postmenopausal Women


name: Compassionate Use of SOM230 for Hyperinsulinemic/Hypoglycemia


clinical_trial_age_range: 20 years to 80 years

name: Effectiveness and Safety of Danshen Injection for Acute Kidney Injury in Primary Nephrotic Syndrome


clinical_trial_age_range: 20 years or older

name: Study of Weekly Paclitaxel With Ramucirumab in Participants With Advanced Gastric Adenocarcinomas


clinical_trial_age_range: 1 year to 16 years

name: A PK and Salvage Study for Children With HIV-infection


name: Bupropion Hydrochloride or Patient's Choice for Smoking Cessation in Patients With Squamous Cell Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy


Stop Hep B @ Birth

clinical_trial_age_range: any age

original_interventions:
HBIG
hepatitis B immune globulin


name: ST266 Eyedrops for the Treatment of Persistent Corneal Epithelial Defects


name: A Study of E3810 With Pre- and Post-Treatment pH Monitoring in Patients With Non-Erosive Gastroesophageal Reflux Disease

original_conditions: Non-erosive Gastroesophageal Reflux Disease


clinical_trial_age_range: 18 years to 55 years

name: A Study of 1592U89 and Ethanol When Given Together to HIV-Infected Patients


clinical_trial_age_range: 25 years to 49 years

name: Investigating the Effects of Dietary Phospholipids on Stress Reactivity and Recovery


name: PREVAIL: PREvention of VTE After Acute Ischemic Stroke With LMWH Enoxaparin ( - VTE: Venous Thromboembolism - LMWH: Low Molecular Weight Heparin)


name: Dutasteride to Treat Spinal and Bulbar Muscular Atrophy (SBMA)

original_conditions:
Kennedy's Disease
Spinal and Bulbar Muscular Atrophy


clinical_trial_age_range: 18 years to 45 years

name: Influence of Antipruritics on the Dermal Blood Flow Response to Histamine, Cinnamaldehyde and Capsaicin.


name: Diagnostic Utility of SGLT1/2 Inhibition to Facilitate Myocardial Glucose Suppression


clinical_trial_age_range: 2 years or older

name: Evaluation of Systemic Exposure to VP-102 in Subjects With Molluscum Contagiosum.


name: Effect of Prolonged PDE-5 Inhibition on Insulin Signaling in Skeletal Muscle.


name: The First-in-human Phase I Trial of PU-H71 in Patients With Advanced Malignancies


clinical_trial_age_range: 13 years to 20 years

name: Immuno & Safety Study of GSK Biologicals' Thio or Preservative Free Hepatitis B Vaccine in Subjects Aged 11-15 Yrs


name: Efficacy and Safety Study of Lomustine/Temozolomide Combination Therapy vs. Standard Therapy for Glioblastoma Patients


name: Exploring the Safety And Tolerability of Doses of E2007 up to a Maximum of 12 mg In Patients With Refractory Partial Seizures


clinical_trial_age_range: 25 years to 60 years

name: Effects of Short-term Intensive Insulin Therapy in Newly Diagnosed Type 2 Diabetes Patients


name: Phase II Study of MEDI4736 Monotherapy or in Combinations With Tremelimumab in Metastatic Pancreatic Ductal Carcinoma

original_conditions: Metastatic Pancreatic Ductal Adenocarcinoma


name: Phase II Trial of EOquin in High-risk Superficial Bladder Cancer


clinical_trial_age_range: 18 years to 75 years

name: Safety, Efficacy, Pharmacokinetic and Pharmacodynamic Study of GLPG0974 in Subjects With Ulcerative Colitis


name: Effects of Food on the Pharmacokinetics of Tesetaxel 10 mg Capsules


clinical_trial_age_range: 16 years to 79 years

name: The Study of Unasyn-S 12g/Day for Community Acquired Pneumonia (CAP)


clinical_trial_age_range: 50 years to 100 years

name: NMDA Enhancement Combined With Omega-3 for Early Dementia


clinical_trial_age_range: 8 years or older

name: A Study of Efficacy, Safety and Tolerability of Idebenone in the Treatment of Friedreich's Ataxia (FRDA) Patients


clinical_trial_age_range: 18 years or older

name: Pharmacodynamic Study to Assess the Anti-proliferative Activity of the PARP Inhibitor Olaparib in Patients With HPV Positive and HPV Negative HNSCC

original_conditions: Squamous Cell Carcinoma of the Head and Neck


clinical_trial_age_range: 38 years to 80 years

name: Chronic Sildenafil Treatment in Heart Failure


name: Trabectedin in Treating Patients With Metastatic Pancreatic Cancer After First-Line Chemotherapy


name: Tetracycline (Doxycycline) and Post Myocardial Infarction Remodeling


name: A Study of Duvelisib Versus Gemcitabine or Bendamustine in Participants With Relapsed/Refractory Nodal T Cell Lymphoma With T Follicular Helper (TFH) Phenotype


clinical_trial_age_range: 18 years to 65 years

name: Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole


clinical_trial_age_range: 18 years to 70 years

name: Postoperative Pain Management Following Laparoscopic Cholecystectomy


clinical_trial_age_range: 18 years to 90 years

name: Metabolic and Renal Outcomes in Cardiac Surgery Patients Receiving SGLT2 Inhibitors


clinical_trial_overall_status: SUSPENDED

name: A Phase 1a/1b Study to Evaluate the Safety of EZN-4176, in Adult Patients With Castration-Resistant Prostate Cancer


name: Safety and Efficacy of Solithromycin in the Treatment of Nonalcoholic Steatohepatitis Without Cirrhosis


clinical_trial_age_range: 18 years to 50 years

name: TMLI Plus Chemotherapy in High Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia


clinical_trial_age_range: 8 years to 13 years

name: The Effects of Methylphenidate and Non-invasive Brain Stimulation on Inhibitory Control in Children With ADHD

original_conditions: Attention Deficit Hyperactivity Disorder


name: Clinical Study Evaluating the Gastroprotective Effect of Carvedilol in Patients With Ischemic Heart Disease on Aspirin Therapy


name: Phase 1/2 Study of IMC-R117C in Selected Advanced Cancers


name: A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma


name: Camrelizumab in Combination With Apatinib in Advanced ICC: A Single-arm Phase II Study


name: Evaluation of Biomarkers Associated With Response to Subsequent Therapies in Subjects With HER2-Positive Metastatic Breast Cancer


name: Study of Camrelizumab Plus Chemotherapy as Neoadjuvant Therapy in Participants With Triple Negative Breast Cancer (TNBC)


name: GEN3014 Trial in Relapsed or Refractory Hematologic Malignancies


name: Phase III Trial of Vinflunine Plus Best Supportive Care vs. Best Supportive Care in Patients With Transitional Cell Carcinoma (TCC) of the Urothelial Tract

original_conditions:
Bladder Cancer
Bladder Neoplasms

original_conditions: Transitional Cell Carcinoma of the Urothelial Tract


name: Effectiveness of Bupropion in Treating Marijuana Dependent Individuals


Therapy for Children With Neuroblastoma

clinical_trial_age_range: up to 18 years


name: A Study of Romiplostim for the Treatment of Refractory Transfusion-dependent NSAA


clinical_trial_age_range: 71 years or older

name: Trial to Evaluate Radiotherapy With or Without CBDCA in Elderly Patients With Non-Small Cell Lung Cancer (JCOG0301)


clinical_trial_age_range: 16 years or older

name: Efficacy of Symbicort pMDI Administered Once Daily in Adolescents and Adults During 12 Weeks - STEM


clinical_trial_age_range: 45 years to 80 years

name: P2X7 Receptor, Inflammation and Neurodegenerative Diseases


name: Treatment of Diabetes After Gastric Bypass With Sitagliptin


name: Cetuximab and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed by Surgery


name: Golcadomide and Rituximab as Bridging Therapy for Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma Before CAR T-cell Therapy

original_conditions: Recurrent Transformed Non-Hodgkin Lymphoma

original_conditions: Recurrent Primary Mediastinal Large B-Cell Lymphoma

original_conditions: Refractory Primary Mediastinal Large B-Cell Lymphoma

original_conditions: Large B-Cell Lymphoma With IRF4 Rearrangement

original_conditions: Recurrent Intravascular Large B-Cell Lymphoma

original_conditions: Refractory Intravascular Large B-Cell Lymphoma

original_conditions: Recurrent Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type

original_conditions: Refractory Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type

original_conditions: Refractory Transformed Non-Hodgkin Lymphoma

original_conditions: Recurrent EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified

original_conditions: Refractory EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified

original_conditions: Recurrent T-Cell/Histiocyte-Rich Large B-Cell Lymphoma

original_conditions: Refractory T-Cell/Histiocyte-Rich Large B-Cell Lymphoma

original_conditions: Recurrent Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type

original_conditions: Recurrent Diffuse Large B-Cell Lymphoma Activated B-Cell Type

original_conditions: Refractory Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type

original_conditions: Refractory Diffuse Large B-Cell Lymphoma Activated B-Cell Type

original_conditions: Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified

original_conditions: Refractory Diffuse Large B-Cell Lymphoma, Not Otherwise Specified

original_conditions: Recurrent Aggressive B-Cell Non-Hodgkin Lymphoma

original_conditions: Refractory Aggressive B-Cell Non-Hodgkin Lymphoma

original_conditions: Recurrent Diffuse Large B-Cell Lymphoma Associated With Chronic Inflammation

original_conditions: Refractory Diffuse Large B-Cell Lymphoma Associated With Chronic Inflammation

original_conditions: Recurrent High Grade B-Cell Lymphoma, Not Otherwise Specified

original_conditions: Refractory High Grade B-Cell Lymphoma, Not Otherwise Specified

original_conditions: Recurrent ALK-Positive Large B-Cell Lymphoma

original_conditions: Refractory ALK-Positive Large B-Cell Lymphoma


name: Safety and Efficacy of Aripiprazole and Ziprasidone Among Schizophrenic Patients With Metabolic Syndrome


name: Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study


name: A Study to Evaluate the Combination of Platinum-pemetrexed Based Chemotherapy Plus Lorlatinib in ALK Positive Non-Small Cell Lung Cancer (NSCLC) With Exclusively Extracranial Disease Progression on Lorlatinib


clinical_trial_age_range: 21 years to 40 years

name: Effects of Cortical Dopamine Regulation on Drinking, Craving, and Cognitive Control


clinical_trial_age_range: 2 years to 11 years

name: Efficacy and Safety of ZSP1273 in Children 2-11 Years Old With Influenza A


clinical_trial_age_range: 50 years to 75 years

name: Efficacy and Safety Study of Intravitreal Triamcinolone to Treat Diffuse Diabetic Macular Edema


clinical_trial_age_range: 18 years to 75 years

name: A Study of the Safety and Efficacy of Tofimilast in Adult Asthmatics


clinical_trial_age_range: any age

name: A Pharmacovigilance Study of Brain Oedema


name: Study Evaluating the Safety and Tolerability of NCX 4251 for the Treatment of Acute Exacerbations of Blepharitis


name: Hexaminolevulinate (HAL) Photodynamic Therapy (PDT) of Cervical Intraepithelial Neoplasia (CIN) Grade 1

original_interventions: HAL Hexaminolevulinate


clinical_trial_age_range: 18 years to 18 years

name: Safety and Efficacy Study of Mix Vaccine in Pancreatic Carcinoma Patient


clinical_trial_age_range: 18 years or older

name: Botulinum Toxin-A for Hidradenitis Suppurativa


name: SGLT2i to Prevent of Liver Complications in Patients With CHB and Diabetes Mellitus


name: Liposomal Bupivacaine vs Continuous Nerve Catheters for Below the Knee Amputations

original_interventions: Bupivacaine Hydrochloride 0.5 % Injectable Solution


clinical_trial_age_range: 45 years to 100 years

name: A Clinical Trial to Compare Efficacy and Tolerability of Faslodex With Arimidex in Patients With Advanced Breast Cancer


name: Evaluation of the Efficacy and Safety of Nifekalant Hydrochloride (NIF) Injection.


name: Study of CAR-T Cell Therapy in the Treatment of Relapsed/Refractory Hematological Malignancies


clinical_trial_age_range: 50 years to 80 years

name: Effect of Vardenafil on Blood Pressure in Patients With Erectile Dysfunction Who Received Concomitant Doxazosin GITS


name: Testolactone for the Treatment of Girls With LHRH Resistant Precocious Puberty


clinical_trial_age_range: 8 years to 18 years

name: Salvage Therapy With High/Low Methotrexate for Loss of Response to Infliximab Dose Escalation


name: IGF-I Stimulation of Collagen Synthesis in Ehlers-Danlos Patients


name: Effects of Mirtazapine on Appetite in Advanced Cancer Patients


clinical_trial_age_range: 18 years to 65 years

name: Low Dose Versus High Dose Methylene Blue in Septic Patients


name: Phase I/II Study of hLL1 in Multiple Myeloma

original_conditions:
Multiple Myeloma
Myeloma, Plasma-Cell


clinical_trial_age_range: 35 years to 80 years

name: Premedication with Intranasal Dexmedetomidine in Sedation of Patients Undergoing Total Knee Arthroplasty


name: Low Dose Continuous Furosemide Effect on Cardiac Surgery Patients With Kidney Dysfunction


clinical_trial_age_range: 45 years or older

name: Abaloparatide Added to Ongoing Denosumab vs Continued Denosumab Alone


name: A Study Evaluating Efficacy and Safety of VX-548 for Acute Pain After an Abdominoplasty


name: A Study to Evaluate the Safety and Efficacy of Rencofilstat in Adult Subjects With NASH F3


clinical_trial_age_range: 42 days to 69 days

name: Immunogenicity and Safety of GlaxoSmithKline Biologicals' Infanrix™-IPV+Hib Vaccine


clinical_trial_age_range: 18 years to 80 years

name: 18F-FDG Uptake Heterogeneity Predicts Pyrotinib Response


clinical_trial_age_range: 6 months to 12 years

name: Analgesia Evaluation of an Ultrasound-guided Technique for Inguinal Hernia Surgery in Children in Children


name: Comparing Efficacy and Safety of Insulin Detemir Plus Insulin Aspart and NPH Insulin Plus Human Soluble Insulin With or Without Metformin in Chinese Patients With Type 2 Diabetes

original_interventions:
insulin aspart
insulin detemir

original_conditions:
Diabetes
Diabetes Mellitus, Type 2


name: Study of Sunobinop on Alcohol Consumption in Alcohol Use Disorder


clinical_trial_age_range: 40 years to 80 years

name: Preventing ESRD in Overt Nephropathy of Type 2 Diabetes


name: A Phase I, Pharmacological, and Biological Study of OSI-774 in Combination With FOLFOX 4 (5-FU, Leucovorin, and Oxaliplatin) and Bevacizumab (Avastin) in Patients With Advanced Colorectal Cancer

original_conditions: Signet Ring Adenocarcinoma of the Rectum


name: First-in-Human Dose Expansion Study of XMT-1536 in Cancers Likely to Express NaPi2b


name: Prevention of HIV1 Mother to Child Transmission Without Nucleoside Analogue Reverse Transcriptase Inhibitors in the Pre-partum Phase. ANRS 135 Primeva

original_interventions: Kaletra lopinavir


clinical_trial_age_range: 18 years to 70 years

name: Safety Study of Pegylated Interferon Lambda Plus Single or 2 Direct Antiviral Agents With Ribavirin


name: Dosage of Mepivacaine in Ultrasound Axillary Block


clinical_trial_age_range: 55 years to 85 years

name: An Efficacy and Safety Trial of Verubecestat (MK-8931) in Mild to Moderate Alzheimer's Disease (P07738)


name: Pembrolizumab Plus Epacadostat, Pembrolizumab Monotherapy, and the EXTREME Regimen in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (KEYNOTE-669/ECHO-304)


clinical_trial_age_range: 40 years or older

name: Stop Atherosclerosis in Native Diabetics Study


clinical_trial_age_range: 4 weeks to 11 years

name: Doravirine (DOR) in Human Immunodeficiency Virus (HIV)-Infected Children Ages 4 Weeks to <12 Years and <45 kg (MK-1439-066)

original_conditions: Human Immunodeficiency Virus (HIV) Infection


name: Papaverine and Stereotactic Body Radiotherapy (SBRT) for Non Small Cell Lung Cancer (NSCLC) or Lung Metastases


name: Denosumab in Metabolic Bone Disease in Chronic Intestinal Failure Patients


clinical_trial_age_range: 18 years to 85 years

name: Flaxseed, Aromatase Inhibitors and Breast Tumor Characteristics


clinical_trial_age_range: 19 years or older

name: Study of GX-I7 in Combination With Pembrolizumab in Refractory or Relapsed (R/R) TNBC Subjects(GX-I7-CA-006/KEYNOTE-899)


clinical_trial_age_range: 20 years to 80 years

name: Comparison of Meperidine and Fentanyl on Pain Scale and QOL in Brachytherapy


clinical_trial_age_range: 18 years to 60 years

name: The Effect Of PF-03654764 +/- Allegra On Symptoms Of Allergic Rhinitis


clinical_trial_age_range: 18 years or older

name: Study In Women With Severe Diarrhea-Predominant Irritable Bowel Syndrome Having Failed Conventional Therapy

original_conditions:
Irritable Bowel Syndrome (IBS)
Irritable Colon


clinical_trial_age_range: 40 years to 65 years

name: Efficacy of Suvorexant in the Treatment of Hot Flash-associated Insomnia


clinical_trial_age_range: 18 years to 40 years

name: Effect of Different Ingestion Doses of Celastrol on Human Sperm Motility


clinical_trial_age_range: 20 years or older

name: Study of AZD6738 and Olaparib Combination Therapy in Relapsed Small Cell Lung Cancer Patients [SUKSES-N2]


name: Treatment of Cushing's Disease With R-roscovitine


name: Cervical Cancer Screening Study in Brazil


clinical_trial_age_range: 12 years to 17 years

name: Efficacy and Safety of Delgocitinib Cream in Adolescents 12-17 Years of Age With Moderate to Severe Chronic Hand Eczema


clinical_trial_age_range: 10 years to 18 years

name: A Study to Evaluate the Safety, Tolerability, and Efficacy of BIIB017 (Peginterferon Beta-1a) in Pediatric Participants for the Treatment of Relapsing-Remitting Multiple Sclerosis


clinical_trial_age_range: 6 months to 59 months

name: Adherence to Antimalarial Drugs in Sierra Leone


clinical_trial_age_range: any age

name: Pharmacokinetics of Alglucosidase Alfa in Patients With Pompe Disease


name: Safety and Efficacy Study of P276-00 in Combination With Radiation in Subjects With Advanced Head and Neck Cancer

original_conditions: Squamous Cell Carcinoma of Head and Neck


clinical_trial_age_range: 18 years to 55 years

name: Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 139 in Healthy Subjects and Subjects With Moderate to Severe Psoriasis


name: The Efficacy of Bevacizumab and Serplulimab Combined With Recombinant Mutant HumanTumor Necrosis Factor(rmhTNF-NC) in the Treatment of Malignant Ascites


clinical_trial_age_range: 18 years to 75 years

name: A Phase II Study of Total Neoadjuvant Therapy for Locally Advanced Gastric Cancer


name: TBP Study With Capecitabine Plus Minus Trastuzumab


name: Vitamin B-6 and Glutathione on Inflammation, Homocysteine, Oxidative Stress and Antioxidant Capacities


clinical_trial_age_range: 17 years to 50 years

name: D-chiro-Inositol in Overweight Type 1 Diabetes Patients


clinical_trial_age_range: 50 years to 80 years

name: Identifying Potential Effects of Liraglutide on Degenerative Changes


name: A Multiple-dose Study of the Safety and Tolerability of REGN88(SAR153191) in Rheumatoid Arthritis Subjects


clinical_trial_age_range: 18 years to 70 years

name: Modulation Therapy for Locally Advanced NPC Based on Plasma EBV DNA Level Post-ICT


clinical_trial_age_range: 2 years to 6 years

name: Children of Age 2-6years Undergoing Elective Surgery Will be Divided Into Two Groups Randomly. This Study Aims to Evaluate if Intranasal Dexmedetomidine is Better Than Intranasal Ketamine in Producing Sedation and Reducing Parent Separation Anxiety Before Surgery.


clinical_trial_age_range: 18 years to 65 years

name: Open Randomized Controlled Trial to Evaluate the Efficacy and Safety of Remifentanil Versus Nitrous Oxide in External Cephalic Version at Term in Singleton Pregnancy in Breech Presentation


clinical_trial_age_range: 18 years to 85 years

name: Cardiac Changes in Early Parkinson's Disease: a Follow Up Study


name: Feasibility Study of Pemetrexed in Combination With Cisplatin or Carboplatin as Adjuvant Treatment of Non-Small Cell Lung Cancer


name: One-Year Safety and Tolerability Study of Azilsartan Medoxomil in Participants With Essential Hypertension


clinical_trial_age_range: 50 years or older

name: Study of PF-04523655 (REDD14NP) In Subjects With Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (Wet AMD)


clinical_trial_age_range: 18 years to 99 years

name: Phase I Trial of Afatinib and Trastuzumab in HER2 Overexpressing Cancer.

original_interventions: Herceptin trastuzumab


clinical_trial_age_range: 18 years or older

name: Trial to Assess the Safety and Preliminary Efficacy of GEN1055 on Malignant Solid Tumors as Monotherapy and as Combination Therapy


clinical_trial_age_range: 55 years to 90 years

name: Minocycline in Patients With Alzheimer's Disease


clinical_trial_age_range: 20 years to 40 years

name: Vitamin D Status After Single Oral Dose of Cholecalciferol in Low Fat Meal Compared to High-fat Meal


name: A Pediatric Phase I Trial of RMP-7 and Carboplatin in Brain Tumors


clinical_trial_age_range: 21 years to 65 years

name: Safety, Tolerability and Activity Study of Ibudilast in Subjects With Progressive Multiple Sclerosis

original_conditions: Multiple Sclerosis, Secondary Progressive


clinical_trial_age_range: 12 months to 21 years

name: Selpercatinib for the Treatment of Advanced Solid Tumors, Lymphomas, or Histiocytic Disorders With Activating RET Gene Alterations, a Pediatric MATCH Treatment Trial

original_conditions: Hematopoietic and Lymphatic System Neoplasm

original_conditions: Recurrent Peripheral Primitive Neuroectodermal Tumor

original_conditions: Refractory Histiocytic and Dendritic Cell Neoplasm

original_conditions: Recurrent Histiocytic and Dendritic Cell Neoplasm

original_conditions: Refractory Langerhans Cell Histiocytosis

original_conditions: Refractory Peripheral Primitive Neuroectodermal Tumor


name: Adjuvant Systemic Chemotherapy With or Without HAI-FUDR in Patients With Resected CRLM


clinical_trial_age_range: 19 years to 75 years

name: The Practical Evidence of Antidiabetic Combination Therapy in Korea


clinical_trial_age_range: up to 21 years

name: Lenalidomide and Dinutuximab With or Without Isotretinoin in Treating Younger Patients With Refractory or Recurrent Neuroblastoma


clinical_trial_age_range: 19 years or older

name: Eribulin Plus Gemcitabine (EG) vs Paclitaxel Plus Gemcitabine (PG) in HER2-Negative Metastatic Breast Cancer


clinical_trial_age_range: any age

name: Randomized Clinical Trial With Aminocaproic Acid in the Prevention of Exodontic Bleeding in Anticoagulants Patients


clinical_trial_age_range: 40 years or older

name: Efficacy, Safety and Tolerability of Aclidinium Bromide/Formoterol Fumarate Compared With Aclidinium Bromide and Formoterol Fumarate in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)


name: Study of Acalabrutinib (ACP-196) Versus Ibrutinib in Previously Treated Participants With High Risk Chronic Lymphocytic Leukemia (CLL)


clinical_trial_age_range: 18 years to 49 years

name: 24-week Study Comparing Lixisenatide to Sitagliptin as add-on to Metformin in Obese Type 2 Diabetic Patients Younger Than 50 Years


clinical_trial_age_range: 7 years to 18 years

name: A Trial of Three- and Seven-days Insulin Infusions Set


clinical_trial_age_range: 30 years to 75 years

name: Genetic Basis for Heterogeneity in Response of Plasma Lipids to Plant Sterols


clinical_trial_overall_status: AVAILABLE

clinical_trial_age_range: 12 years or older

name: Domperidone Expanded Access Treatment Program


clinical_trial_age_range: 18 years to 75 years

name: Study of Roxadustat (FG-4592) in Participants With End-Stage Renal Disease Receiving Maintenance Hemodialysis


clinical_trial_age_range: 18 years to 65 years

name: Duloxetine for the Treatment of Obsessive Compulsive Disorder (OCD)


clinical_trial_age_range: 20 years to 70 years

name: SOX as Adjuvant Chemotherapy for Resectable Gastric Cancer


clinical_trial_age_range: 18 years to 80 years

name: Safety and Efficacy of a Monoclonal Antibody for Treatment of Rheumatoid Arthritis.


name: Comparison of Two NN5401 Formulations Versus Insulin Glargine, All in Combination With Metformin in Subjects With Type 2 Diabetes

original_interventions:
insulin aspart
insulin degludec


name: Cohort Study in Senegal Comparing Artesunate + Amiodaquine in the Treatment of Repeated Uncomplicated Plasmodium Falciparum Malaria Attacks


clinical_trial_age_range: 18 years to 70 years

name: Oral Paricalcitol in Renal Transplant Recipients for Reducing Albuminuria


clinical_trial_age_range: 18 years or older

name: Dendritic Cell Vaccine Study (DC/PC3) for Prostate Cancer


name: Endocrine Therapy Plus CDK4/6 in First or Second Line for Hormone (SONIA) Receptor Positive Advanced Breast Cancer


name: Zanubrutinib Combined With BEAM for ASCT in Relapsed and Refractory DLBCL